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To my dear children
Ronja, Tuuli, Ilpo and Heini
Journey
Make haste with care,
the never-ending sky above
embraces dreams.
To our feet
it lowers its white stars,
through which we thirstily wade,
the moon imprinted on our brow.
In the night
blue diamonds whisper,
the sounds of human dreams and longing.
Make haste with care,





on unelmien loputon syli.
Se on laskenut valkeat tähtensä
jalkojemme juureen
ja me kahlaamme janoisina,
kuun merkki otsallamme.
Yössä kuuluu sinisten jalokivien kuiske,
ihmisten unten ja kaipuun äänet.
Kiiruhda varoen,
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1 ABSTRACT
Background: Dementing diseases lead to disability, the need for help, and a greater need for institutional 
care, and pose a potential economical burden. Therefore, vulnerable persons with dementia require high-
quality health care, rehabilitation and sufficient social services to support their autonomy and to postpone 
permanent institutionalization. In this way, society could offer these elderly persons better quality of life 
while economizing on its financial resources.
Aims: This study sought to investigate pitfalls in the care of patients with dementia. The first objective 
was to study the impact of weight-bearing restrictions on the rehabilitation of elderly hip fracture patients 
with or without dementia (I). The second objective was to study the impact of inappropriate drug (II) or 
atypical or conventional antipsychotic use (III) on two-year mortality or hospital admissions. The third 
aim was to examine the use of, the unmet needs for, and satisfaction with social services among spousal 
caregivers of persons with dementia (IV), as well as the use of guardianship or financial powers of 
attorney (V) with a large-scale questionnaire given to caregiver spouses with AD.
Methods: Study I comprised 98 elderly hip fracture patients in Lahti, 36 of whom suffered dementia. We 
examined the surgical method, post-operative weight-bearing restrictions, need for physiotherapy in days, 
and ability to learn to walk in six weeks. Studies II and III comprised 425 elderly patients in acute 
geriatric wards or nursing homes in Helsinki, 255 of whom suffered dementia. We investigated all the 
drugs used and categorized them according to the Beers 1997 and 2003 lists for potentially inappropriate 
drugs (PID) (II), atypical or conventional antipsychotic use, or non-use of antipsychotics (III) in order to 
study the impact of such drugs on two-year mortality or hospital admissions. The data for studies IV and 
V were collected with a postal questionnaire sent to a random sample of 1 943 Alzheimer drug users 
living in five areas of Finland and selected from the register of Finland’s Social Insurance Institution.
Results: Mean age in these studies ranged from 78 to 86 years. In the sample of hip fracture patients, 38% 
received weight-bearing restrictions from their surgeon, mostly after osteosynthesis (89%), which was the 
most common surgical method. This restriction, especially in group of patients with dementia, was 
associated with a longer rehabilitation period (73.5 days vs. 45.5 days, p=0.03) and the inability to learn 
to walk after six weeks (p<0.001).Almost half (44%) of the pre-surgery home-dwellers with dementia in 
our sample required permanent hospitalization after hip fracture. Only 1 of the 12 patients with dementia 
and a weight-bearing restriction was able to learn to walk in six weeks.
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In our sample of studies on drug treatment, 36.2% received at least one PID. Whether a patient suffered 
dementia showed no effect on this proportion whether. The most common PIDs in Finland were 
temazepam (over 15 mg), oxybutynin, and dipyridamole. However, PID use failed to predict mortality or 
the use of health services.
Nearly half (48.4%) of the patients with dementia used antipsychotic medication, 37.4% conventional 
neuroleptics (N=95), and 11% atypical antipsychotics (N=28). The two-year mortality of non-users of 
antipsychotics did not differ from that of users of conventional or atypical antipsychotics (49.6% 
vs.45.3% vs.32.1%, p=0.195). The mean number of hospital admissions was highest among non-users 
(p=0.029). In the Cox proportional hazard model, a high number of medications (HR 1.12, p<0.001) and 
the use of physical restraints (HR 1.72, p=0.034) predicted higher mortality at two years, while the use of 
atypical antipsychotics (HR 0.49, p=0.047) showed a protective effect, if any. 
Spousal caregivers of persons with AD are old and many are in poor health. Disabilities and behavioral 
symptoms were common among the demented spouses. The services most often offered to AD families 
included financial support from the community (36%), technical devices (33%), physiotherapy (32%), 
and respite care in nursing homes (31%). Those services most often needed included physiotherapy for 
the spouse with dementia (56%), financial support (50%), house cleaning (41%), and home respite 
(40%). Only a third of the caregivers were satisfied with these services, and 69% felt unable to influence 
the range of services offered. 
Legal guardians were used by 4.3% of our sample, while the use of financial powers of attorney was 
37.8%. Almost half (47.9%) of the couples expressed an unmet need for discussion with their doctor 
about medico-legal issues, while only 9.9% stated that their doctor had informed them of such matters.
Conclusions: Several pitfalls can be recognized in the Finnish health care and social services systems 
concerning the care of patients with dementia. Although we already have many practical methods to 
develop the medical and social care of persons with AD, these patients and their families require better 
planning and tailoring of such services.
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ABSTRACT IN FINNISH
Karikoita dementoituvien henkilöiden hoidossa
Taustaa: Dementoivat sairaudet johtavat aina toimintakyvyn heikentymiseen, avun ja lopulta useimmiten 
myös laitoshoidon tarpeeseen. Dementiaa sairastavat henkilöt tarvitsevat erityisen haavoittuvuutensa 
vuoksi asianmukaista terveydenhoitoa, kuntoutusta ja riittäviä sosiaalisia palveluja, jotta heidän autono-
miaansa voidaan tukea ja laitoshoidon tarvetta myöhentää. Tämä voisi paitsi parantaa näiden iäkkäiden 
ihmisten elämänlaatua, myös tuoda taloudellisia säästöjä yhteiskunnalle.
Tutkimuksen tarkoitus: Tutkimuksen tarkoituksena oli selvittää tiettyjä kliinisiä karikoita dementiaa 
sairastavien henkilöiden hoidossa. Tutkimme lonkkamurtuman jälkeisen varausrajoituksen merkitystä 
kuntoutuksessa (I), sopimattomiksi luokiteltujen lääkkeiden (II) ja uuden polven, epätyypillisten psykoo-
silääkkeiden ja vanhan polven psykoosilääkkeiden käytön (III) merkitystä kahden vuoden kuolleisuuteen 
ja sairaalahoitoihin hyvin iäkkäillä henkilöillä, joista toisella ryhmällä oli dementia, toisella ei. Laajan 
Alzheimerin tautia sairastavien puoliso-omaishoitajien kirjekyselyn tarkoituksena oli selvittää sosiaali-
palvelujen (IV) ja edunvalvonnan ja pankkivaltuutuksen käyttöä (V) sekä tutkia näiden perheiden palve-
lujen tarvetta ja tarjottujen palvelujen kohtaamista, sekä kyseisten omaishoitajien tyytyväisyyttä saamiin-
sa palveluihin. 
Menetelmät: Tutkimus I koostui 98 iäkkäästä lahtelaisesta lonkkamurtumapotilaasta, joilla 36:lla oli 
dementia. Selvitimme käytetyn leikkausmenetelmän, leikkauksen jälkeisen kirurgin asettaman varausra-
joitusohjeen, fysioterapian tarpeen päivissä ja sen, kykenikö potilas oppimaan kävelemään itsenäisesti 
tukien kanssa tai ilman kuuden viikon aikana leikkauksesta. Tutkimusten II ja III aineistona oli 425 iäkäs-
tä helsinkiläistä potilasta, joilla 255:llä dementia, akuuteilta geriatrian osastoilta tai hoivakodeista. Hei-
dän kaikki käyttämänsä lääkkeet selvitettiin ja luokiteltiin Beers 1997 ja 2003 sopimattomien lääkkeiden 
listan mukaan (II), ja psykoosilääkkeiden käytön suhteen potilaat jaettiin kolmeen ryhmään: uuden pol-
ven ja vanhan polven psykoosilääkkeiden käyttäjät ja ne, jotka eivät käyttäneet mitään psykoosilääkettä 
(III) tarkoituksena tutkia näiden lääkkeiden käytön merkitystä kahden vuoden kuolleisuuteen ja sairaala-
hoitoihin. Aineisto tutkimuksia IV ja V varten kerättiin postikyselynä valikoimattomasta 1943 Kelan re-
kisterin mukaan Alzheimerin taudin lääkkeiden lääkekorvausta saavien ryhmästä viideltä eri alueelta 
Suomesta. 
Tulokset: Tutkimushenkilöiden keski-ikä vaihteli välillä 78- 86 vuotta. Lonkkamurtuma-aineistossa 
38%:lle potilaista kirurgi oli antanut varausrajoitusohjeen, useimmiten osteosynteesin (89%) jälkeen, 
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mikä oli yleisin käytetty leikkausmenetelmä. Tämä varausrajoitus liittyi erityisesti dementiaa sairastavien 
ryhmässä pidempään kuntoutusaikaan (73.5 pv vs. 45.5 pv, p=0.03) ja siihen, ettei potilas oppinut itse-
näistä kävelyä kuuden viikon aikana (p<0.001). Melkein puolet (44%) aiemmin kotona asuneista demen-
tiaa sairastavista potilaista joutui pysyvään laitoshoitoon lonkkamurtuman jälkeen. Vain yksi kahdesta-
toista dementiaa sairastavasta potilaasta, joille oli määrätty varausrajoitus, oppi itsenäisen kävelyn 
kuuden viikon aikana. Lääkityksiä käsittelevässä aineistossamme 36.2%:lla oli käytössä vähintään yksi 
sopimaton lääke, riippumatta siitä, oli potilailla dementia vai ei. Yleisin sopimaton lääke Suomessa oli 
tematsepaami yli 15 mg, oksybutyniin ja dipyridamoli. Kuitenkaan sopimattomien lääkkeiden käyttö ei 
liittynyt kuolleisuuteen tai terveyspalveluiden käyttöön. Lähes puolella (48.4%) dementiaa sairastavista 
potilaista oli käytössä psykoosilääke, useimmilla (37.4%) vanhan polven (N=95) ja 11.0%:lla uuden 
polven psykoosilääke(N=28). Kun verrattiin niitä, jotka eivät käyttäneet mitään psykoosilääkettä, sekä 
vanhan ja uuden polven psykoosilääkkeiden käyttäjien ryhmiä, eroa kahden vuoden kuolleisuudessa ei 
havaittu (49.6% vs.45.3% vs.32.1%, p=0.195). Sairaalahoitojen määrä oli suurin niillä, jotka eivät käyt-
täneet mitään psykoosilääkettä (p=0.029). Coxin regressiomallissa runsas lääkkeiden määrä (HR 1.12, 
p<0.001) ja lepositeiden käyttö(HR 1.72, p=0.034) ennustivat lisääntynyttä kuolleisuutta kahden vuoden 
kuluttua, kun taas uuden polven psykoosilääkkeiden käyttö oli pikemminkin suojaava tekijä (HR 0.49, 
p=0.047). 
Alzheimerin tautia sairastavien henkilöiden, joilla oli heikko toimintakyky ja paljon käytöshäiriöitä, puo-
liso-omaishoitajat olivat iäkkäitä ja monella itselläänkin heikko terveydentila. Palvelut, joita näille per-
heille tarjottiin eniten olivat omaishoidontuki (36%), tekniset apuvälineet (33%), fysioterapia (32%) ja 
lyhytaikainen lomapaikka sairastuneelle laitoksessa (31%). Perheet toivoivat kuitenkin eniten fysiotera-
piaa Alzheimerin tautia sairastavalle (56%), omaishoidontukea (50%), kodin siivousta (41%) ja kotiin 
tulevaa hoitajaa pariksi tunniksi kerrallaan (40%). Vain kolmasosa omaishoitajista oli tyytyväisiä palve-
luihin, ja 69% koki, ettei heillä itsellään ole vaikutusmahdollisuutta siihen, mitä palveluja heille tarjotaan. 
Edunvalvontaa käytti 4.3%, taloudellinen valtakirja oli taas useammalla (37.8%). Lähes puolet (47.9%) 
pariskunnista ilmoitti tarvitsevansa keskustelua hoitavan lääkärin kanssa Alzheimerin tautia sairastavan 
taloudellisten asioiden hoitoon liittyvistä seikoista, mikä oli toteutunut vain 9.9%:lla perheistä.
Johtopäätökset: Suomalaisessa sosiaali- ja terveydenhuoltojärjestelmässä on tunnistettavissa useita de-
mentiaa sairastavan henkilön hoitoon liittyviä karikoita. Siitä huolimatta, että meillä on jo olemassa mo-
nia käytännöllisiä menetelmiä kehittää dementiaa sairastavien avo- ja laitoshoitoa, me tarvitsemme 
 uudenlaista suunnittelua ja palvelujen räätälöintiä näiden perheiden omien tarpeiden mukaisesti. 
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2 INTRODUCTION
During the last century, our dream has become true: we now live to very old ages. As a consequence, 
however, the aged population has grown exponentially. With revolutionary advancements in the treatment 
of cardiovascular diseases, cognitive disorders, especially AD, have taken their place as the most 
challenging diseases in elderly populations. About 120 000 persons in Finland suffered from dementia in 
2006, with an incidence of about 13 200 new cases annually, mostly (70%) AD (Viramo and Sulkava 
2006). According to the registers of Finland’s Social Welfare Office, about 25 000 persons received 
proper diagnosis and treatment of AD in 2005 (http://www.kela.fi/in/internet/suomi.nsf/NET/
131201115055HR?openDocument). Dementia is the most important disease leading to the need of long-
term institutionalization, and is thus the most challenging disorder to handle, both individually and 
economically. According to data from the Stakes Center for Welfare and Health Research (Sosiaali- ja 
terveysalan tutkimus- ja kehittämiskeskus), about 90% of persons currently living in long-term care 
suffer cognitive impairment (Noro et al. 2005).
While the cause of AD remains unknown, recent research describes AD as a multifactorial disease for 
which the risk factors are largely the same as those for cardiovascular diseases, such as hypercholesterolemia, 
hypertension, obesity, diabetes, and a sedentary life style (Kivipelto et al. 2006). Old age and low 
education also increase the risk for AD. The main characteristics of AD include progressive impairment 
of short-term episodic memory as well as symptoms of aphasia, apraksia, agnosia, or executive domain 
(NINCDS-ADRDA diagnostic criteria). Behavioral disorders are also very common and may vary as the 
disease develops.
Most persons with dementia are home-dwellers and are cared for by those closest to them, usually 
relatives. About a third of them have a spousal caregiver. Persons with dementia have a strong need for 
health care services, and their functioning is easily threatened in by acute diseases or accidents, or 
inappropriate medications, care, or services. From the point of view of the family, these persons require 
continuous practical and emotional support, which also affects the lives of the caregivers, who are 
themselves at risk for mental disorders (Saarenheimo 2007). The legal capacity of persons with AD is 
equally impaired, thus leading to the need for new strategies for handling financial affairs in such families 
(Wadley et al. 2003). In this study, we focused on some pitfalls, which may lead to increased use of social 
and health care services or the unnecessarily early institutionalization and mortality of persons with 
dementia, in order to find new solutions for the treatment and service practices of such families.
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3 REVIEW OF THE LITERATURE
3.1 Short historical overview of AD
In 1898, Alois Alzheimer revealed that senile dementia, cortical degeneration, and brain atrophy can 
develop without pathology in brain vessels (Alzheimer 1898). In a scientific meeting in 1906, Alzheimer 
described his 51-year-old female patient, Auguste D, who exhibited progressive cognitive impairment, 
neurological symptoms, delusions, hallucinations, and psychosocial disturbances, as an example of pre-
senile dementia (Alzheimer 1907, Bick and Amaducci 1987, Bick et al. 1987). Plaques and neurofibrillary 
tangles were found in the autopsy, as well as arteriosclerotic changes (Maurer et al. 1997, Graeber et al. 
1998). In 1910, Emil Kraepelin called this disease AD in the category of pre-senile dementias in his 
textbook (Roman 2002).
AD remained an academic rarity until the systematic neuropathologic studies of Blessed, Tomlinson, and 
Roth revealed toward the end of 1960s that such histopathological changes are very common in elderly 
patients with dementia (Blessed et al. 1968). AD proved to be the most common cause of dementive 
disorders among elderly patients, and nowadays accounts for 70% of dementias (Viramo and Sulkava 
2006).
3.2 Definition of dementia and AD
The definition of dementia, according to widely used DSM-IV criteria, includes a state in which a patient 
suffers memory impairment and one or more of the following: aphasia, apraxia, agnosia, or disturbances 
in executive functions (American Psychiatric Association 1994; American Psychiatric Association and 
Finnish Psychiatric Association 1997). Cognitive deficits significantly compromise a patient’s social or 
occupational life, in comparison to the patient’s previous level of functioning, and are not allowed to 
occur only in the presence of delirium.
Several definition criteria for AD exist in practise, of which the most common are the NINCDS-ADRDA 
criteria (McKhann et al. 1984). These criteria can serve in the diagnosis of AD as clinically possible or 
probable. An exact and certain diagnosis of AD is possible only when the clinical criteria of AD are 
present and neuropathological changes have been found in an autopsy of the brain. In practice, the 
diagnosis of AD is primarily clinical, and autopsies of the brain are used only in certain, rare situations 
requiring brain surgery.
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3.3 Epidemiology of dementia and AD
Dementive disorders are among the most common diseases affecting the oldest of the elderly (in position 
3 to 5 according to epidemiological studies). Dementia is more common than cerebral infarction, diabetes, 
or breast cancer. In Europe, about 600 000 persons are diagnosed with dementia anually.
In Finland in 2005, about 120 000 persons suffered from any stage of dementia. The incidence of 
dementia is 13 200 of all persons over 64. Of those over 65, 1 in 12 (8%) suffers from moderate or severe 
dementia. Dementive disorders are rapidly becoming more common as the population ages, and their 
prevalence is estimated at between 22% and 35% among persons 85 and older (Viramo and Sulkava 
2006).
The etiology of AD is multifactorial. Established risk factors for AD include old age, heredity, and 
Apolipoprotein E. Recent studies show strong evidence for other risk factors such as hypertension, 
hypercholesterolemia, diabetes, obesity, physical inactivity, a low level of education, and an inactive 
lifestyle (Kivipelto et al. 2005, Kivipelto et al. 2006a,b, Rovio et al. 2005, Rovio et al. 2007, Ngandu et 
al. 2007). Interestingly, most of the risk factors with strong evidence are the same as those for 
cardiovascular diseases (Kivipelto et al. 2005, Kivipelto et al. 2006a,b). Smoking, alcohol abuse, dietary 
factors (e.g. too many saturated fatty acids, lack of omega 3 fatty acids and fish oils), a high level of 
homocysteine, depression, female gender, head injuries, certain medications, stress and social isolation 
are also affiliated with potential risk factors for dementia (Anttila et al. 2004, Laitinen et al. 2006, Viramo 
and Sulkava 2006).
3.4 Pitfalls in the treatment of persons with dementia
The diagnosis, treatment, and care of dementia always constitute multidisciplinary work, including the 
work of caregivers and families. Nevertheless, several pitfalls occur in all phases of the disease. Pitfalls 
may occur as difficulties related to personal and family factors, the treatment of home-dwelling patients 
with dementia in a health care center, social services, hospital treatment and care, and the financial and 
legal matters of the patient with dementia.
Due to weak self-recognition of memory and other cognitive disorders, the person him/herself may ignore 
the first symptoms of dementia and thus delay diagnosis. Cooperation with a person suffering dementia 
may be difficult since s/he may forget instructions or time schedules. The caregiver may also deny the 
situation and require counselling (Kaye 2002; Waldorff et al. 2005). A sedentary lifestyle may lead to 
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weak muscle function and balance, and thus to an increased risk of falls (Oleske et al. 1995). Nutrition 
may be insufficient (Wolf-Klein et al. 1994), especially when the person with dementia lives alone and 
cooks for him/herself. Long distances may lead to insuperable difficulties in obtaining required services, 
especially in sparsely populated countries or areas. Although many recognize the high strain caregivers 
experience, many caregivers fail to use available services (Brodaty et al. 2005).
The health care system in Finland presumes the patient’s ability to make his/her own appointments with 
a doctor or other health care worker. Unfortunately, the very nature of the disease makes meeting such a 
demand for self-action by the patient with dementia almost impossible. Rather, the current requirement 
for self-action easily leads to a lack of follow-up on the patient and possibly increases the risk of 
hospitalization.
Certain difficulties also exist in recognizing dementive disorders in short appointments with a doctor in a 
health care center (Walldorff et al. 2005, Löppönen 2006). The caregiver may not accompany the patient 
in the doctor’s office, and the lack of a detailed patient history from the caregiver may delay diagnosis and 
necessary referrals to a specialist. If the doctor cannot be the patient’s primary care physician, the risk of 
polypharmacy or of prescribing inappropriate medication increases (Löppönen 2006).
From diagnosis to death, dementia takes about 10 to12 years to develop, and among females may take 
even longer (Viramo and Sulkava, 2006). During this period, the person with dementia depends on both 
the health and social service system and his/her family. Depending on several factors, the care of the 
person with dementia may optimally diminish possible complications and lengthen the period of home 
care, or, if unsuccessful, may lead to complications, disability, increased need for help, and early 
institutionalization.
The treatment and care of persons with dementia involves a number of risks for pitfalls, which could lead 
to rapidly weakening functioning of these persons, and thus to the early need for permanent 
institutionalization. These pitfalls may originate with the patient or his/her family, environmental factors, 
primary care and diagnostic procedures, supportive social and health care services, or specific choices in 
the treatment or rehabilitation of these persons. Acute diseases and hospitalization include several 
potential pitfalls, and a number of potential problems also complicate the institutional care of such 
persons (Figure 1). The oversight of symptoms is patognomous in dementia, and often those closest to the 
person with dementia may also deny the cognitive impairment in the early stages of the disease (Soininen 
and Hänninen 2006). Thus, it is very challenging and time-consuming for the doctor to recognize 
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dementia (Waldorff et al. 2005), especially if the patient prefers to tell about other symptoms in the health 
care center.
The health care system in Finland usually relies on the patient’s awareness, which may lead to delays in 
diagnosis, especially when the patient him/herself cannot remember instructions given or time schedules 
and appointments. Research has shown that persons with AD decrease their nutrient intake and lose 
weight even in mild cases of AD (Cronin-Stubbs et al. 1997). A sedentary life style, together with 
depression and social isolation leads to frailty, sarcopenia, vulnerability to complications such as 
infections, falls and fractures. Behavioral symptoms, such as paranoia, and impaired executive functions, 
may lead to high-risk behavior. A caregiver’s help in such situations is valued, but only if the person with 
AD accepts it. Family relationships, the caregiver’s characteristics, interaction between the person with 
AD and his/her caregiver, the symptoms of the disease, and the strain and stress related to care-giving all 
influence the course of the disease.
In the past decade, the health care system in Finland has made progress in the diagnostics and care of AD. 
However, over half of patients with dementia in Finland are under-diagnosed, their comorbid diseases 
remain improperly treated, and inappropriate anticholiergic medication is widely used (Löppönen 2006). 
Nowadays, with AD medication, diagnoses should be performed as early as possible. Nevertheless, delays 
in getting to the memory clinics still occur, families still receive poor information, and the continuity of 
care when the patient is discharged to open care remains poor. Special challenges at the time of diagnosis 
are daunting: patient and caregiver anxiety and depression, the capacity to continue working despite mild 
AD, retaining a driving license, and other issues. The official system of support services is very complex 
and adjusts only rigidly to the needs of these families (Eloniemi-Sulkava et al. 2006). Health care and 
social workers often change, and the flow of information between various services is poor, and disruptions 
in the continuity of care are common. 
The care of acute diseases may encounter delays in getting to the hospital, thus leading to complications. 
The diagnosis of dementia may awaken nihilistic attitudes among professionals with regard to treatment 
and the need for rehabilitation. Friction may exist between hospital and home care services, thus leading 
to difficulties in discharging the patient as well as extended hospital stays. Several studies have suggested 
that patients with AD in institutional care are prone to polypharmacy and the use of a high number of 
psychotropic and inappropriate drugs (Avorn and Gurwitz 1995; Pitkälä et al. 2004; Löppönen 2006). 
Such patients also suffer from malnutrition and poor rehabilitation services, as nonpharmacological 
treatments for behavioral and psychological symptoms of dementia remain scarce (Cronin-Stubb 1997, 
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Pitkälä et al. 2004, Suominen et al. 2004). The continuity of care is important to persons who experience 
difficulty in recognizing his/her own symptoms and who are unable to provide proper anamnesis (Figure 
1).
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Figure 1. Pitfalls in the treatment of persons with dementia
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Figure 1. Pitfalls in the treatment of persons with dementia 
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Finland’s system of social services is very complex and fragmented. Consequently, persons with dementia 
may find it especially difficult to understand and to seek help. Each service provides different social or 
health care workers and the necessary application forms for these services vary and may be complicated 
(Eloniemi-Sulkava et al. 2006) (Figure 2). Navigating these services and submitting the application 
requests to several different offices often requires the assistance of a caregiver. However, those living 
alone are in a much weaker position if assistance with such bureaucracy is unavailable.
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Figure 2. The Finnish social service system for caregiving families with dementia sufferers
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When patients require hospital treatment and care, dementive diseases should be taken into account when 
choosing treatments. Delay in getting to the emergency unit is common due to AD-related loss of insight. 
Drug-related problems include polypharmacy, the use of psychotropics, and inappropriate medications 
and drug interactions. A low level of physical activity while bed-ridden due to acute disease may result in 
poor appetite as well as eating and drinking difficulties. These complications may then lead to increased 
risk for permanent institutionalization and death. Frail elderly patients are prone to infections (Qizilbash 
and Arrieta 2002), cognitive disorders lead to poor cooperation in hospital, and difficulties may exist 
when organizing their discharge. Consequently, rehabilitation is necessary as early as possible.
Most persons with mild or moderate dementia are home-dwellers, about one third of whom have a 
spousal caregiver. Others live alone and are cared for by those closest to them. Financial and legal affairs 
are often matters of considerable concern in families, and even more so for persons with dementia living 
alone. Trustworthy family relationships enable family members to arrange medico-legal matters, such as 
financial powers of attorney or guardianship. Unfortunately, the swindling of elderly persons is also 
possible. On the other hand, persons with dementia frequently harbor paranoid suspicions, regarded as 
one symptom of the disease (Knopman 2002). The most challenging situations involve persons with 
dementia who lack living family members or friends capable of helping them in their daily living.
This thesis focuses on certain clinical pitfalls in the treatment of persons with dementia which may lead 
to complications, and thus increasing early hospitalization or mortality with time, taking into account the 
heavy strain suffered by their caregivers, who carry the greatest responsibility for the care of these frailest 
of home-dwellers. In particular, this thesis focuses on the following issues: rehabilitation according to 
weight-bearing restrictions after hip fracture, the use of potentially inappropriate medication, the use of 
antipsychotics and their prognostic significance, the subjective need for support services for AD families 
and how the official service system responds to their needs, and the use of guardianship and financial 
powers of attorney among care-giving families of persons with AD and their need for information about 
these issues.
3.4.1 Hip fracture and dementia
The incidence of hip fractures increases with old age, with estimates of 8 700 hip fractures annually in 
Finland by 2010. Most patients with hip fractures are females over 80 (Huusko et al. 2006).
25
Risk factors for hip fractures can be divided into two categories: those factors which increase falls and 
those that affect bone density. Both of these factors increase with old age and lack of sufficient physical 
activity. Accordingly, persons with dementia are particularly prone to fractures, of which hip fractures are 
the most dangerous. The front paw walking position, weak balance, low step height, weakening of 
sensomotor functions and sight all impact the risk for fracture. The incidence of osteoporosis increases up 
to 13-fold between the ages of 60 and 80 (Huusko et al. 2006), although the incidence of hip fractures is 
now decreasing nationwide (Couris et al. 2007). While the exact reasons for this are unknown, a healthier 
aging population, increased average body weight, and the improved functional ability of the elderly 
population are of particular interest (Kannus 2006).
3.4.1.1 Treatment of hip fractures
The treatment of hip fractures usually requires two surgical techniques: osteosynthesis or arthroplasty of 
the hip. Osteosynthesis, which enables early rehabilitation with normal postoperative walking, is 
recommended when treating undisplaced hip fractures (Parker and Blundell 1998, Huusko et al. 2006). 
Patients with hip fractures are usually allowed postoperatively to stand and walk normally after total 
arthroplasty or hemiarthroplasty of the hip. This normal weight-bearing with full weight of the leg is also 
usually possible when the surgeon considers the fracture fixation stable (i.e. in undisplaced femoral neck 
fractures fixed with screws). In all other cases involving osteosynthesis with metallic screws and plates, 
only restricted weight-bearing is usually permitted. This practise is international. Estimating the stability 
of osteosynthesis may be difficult, and in certain cases re-operation is necessary, especially when the 
osteosynthesis of femoral neck fractures involves screws (Vajanto et al. 1998). The augmentation of 
osteoporotic fracture osteosynthesis by banked bone or bone substitutes should be considered more often 
in order to increase fracture stability (Kuokkanen et al. 2001).
3.4.1.2 Rehabilitation after hip fractures
Rehabilitation after hip fracture usually begins in the surgical ward immediately after surgery, provided 
no complications preclude it. While the length of hospitalization in surgical wards has been reduced to 
only a few days, postoperative hip fracture rehabilitation in primary care hospitals or specific rehabilitation 
wards usually continues. Few randomized studies have examined the impact of specialized rehabilitation 
on patient recovery and the rehabilitation time needed prior to discharge from the hospital. Some studies 
have shown beneficial effects (Kennie et al. 1988; Cameron et al. 1993; Huusko et al. 2000), while others 
only moderate effects (Jette et al. 1987; Gilchrist et al. 1988; Galvard and Samuelsson 1995). All concur 
that individually-planned rehabilitation designed by a multidisciplinary team comprising a nurse, physical 
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therapist, geriatrician, and orthopaedist yields the best results (Young et al. 1996; Saarela and Valvanne1999; 
Wade et al. 2000). In Finland, however, this is possible only in big cities with access to various specialist 
services. The first Current Guidelines for the Treatment of Hip Fractures have been published in Finnish 
to serve physicians planning the rehabilitation of their hip fracture patients (Huusko et al. 2006).
While most hip fractures occur among the oldest of the elderly, the number of persons with dementia is 
also considerable. Weakening cognition hampers rehabilitation, and persons with dementia having hip 
fractures require special care in order to benefit from rehabilitation. A patient whose surgeon has issued 
a weight-bearing restriction for his/her leg should be capable of understanding and remembering the 
meaning of it: to stand on only one leg and to walk with crutches or a walker in such a way as to avoid 
bearing weight on the injured leg. If the patient has difficulty learning this, the rehabilitation possible in 
such a situation is limited to muscle strengthening and general conditioning while the person remains in 
a wheelchair or lies in bed for the first six weeks after surgery. This more or less leads to the immobilization 
of such persons during the most important period of rehabilitation.
Huusko and her colleaques have studied hip fracture rehabilitation in patients with mild or moderate 
dementia (N=243), and concluded that rehabilitation could be successful in spite of cognitive disorders 
when carried out with a specialized geriatric team (Huusko et al. 2000). In the intervention group, which 
received referrals to the geriatric wards, the length of hospital stay shortened and the risk for readmissions 
decreased, compared to the control group, which received treatment in local hospitals (Huusko et al. 
2000). In their sample, however, by exceptional order of the head of the surgery department, all the 
patients could begin walking normally after surgery, so no weight-bearing restrictions were necessary. 
The potential for the successful rehabilitation of each patient could benefit from a surgeon’s preoperative 
evaluation before choosing the surgical method (Kuokkanen and Korkala1992; Luethje et al. 1995). 
While several studies have examined the impact of various surgical methods on mortality, time in surgery, 
wound infection, mobility, thrombosis, and pulmonary embolism (Gillespie 2001; Bhandari et al. 2003), 
no previous studies have as yet focused on the impact of weight-bearing restrictions.
3.4.1.3 Prognosis of hip fractures
The increased need for permanent institutional care and long rehabilitation periods has had a considerable 
impact not only on the quality of life of these individuals, but also on the costs of care. Mortality among 
hip fracture patients is particularly high: 21% to 33% in Finland during first year. Neither mild dementia 
among home-dwelling elderly patients with hip fracture nor age over 85 showed any impact on mortality. 
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The weak general condition – especially the weak functioning, comorbidity, anemia, delay of surgery for 
more than two days, delay of early rehabilitation, and different postoperative complications – of the 
patient was the most important factor behind the increasing mortality (Huusko et al. 2006).
3.4.2 Potentially inappropriate medication and dementia
3.4.2.1 Drug use among patients with dementia
Persons with dementia usually suffer from many diseases, thus taking a very wide variety of medication. 
Home-dwelling patients with dementia suffer not only from more comorbidity, but also from more 
undiagnosed diseases than do non-demented patients (Löppönen 2006). According to studies by 
Löppönen et al., persons with and without dementia had 8.3 and 6.0 previously diagnosed comorbid 
conditions, and 66% and 45% suffered from at least one undiagnosed, and therefore untreated, disease, 
respectively. Medication use was more common among persons with dementia than among those without: 
5.7 and 3.8 medications, respectively. The use of anticholinergic drugs was especially common among 
home-dwelling persons with dementia in a Lieto study: 45% of persons with mild dementia used such 
drugs, which are considered inappropriate for elderly persons (Löppönen 2006). In Finland, home-
dwelling patients with dementia use more of various kinds of medication, especially psychotropic drugs, 
than do patients without dementia (Hartikainen et al. 2003). A high risk for polypharmacy, adverse 
effects, and drug interactions exists, especially among the frailest patients with dementia, in nursing 
homes and hospitals (Avorn et al. 1995, Gurwitz et al. 2000).
3.4.2.2 Various criteria for potentially inappropriate medication
To improve the quality of medical care for the elderly, various criteria and national guidelines for PID use 
have been created. Zhan et al. (2001) have defined PIDs in two categories: “always avoid” and “rarely 
appropriate”. In Sweden, the Socialstyrelsen of Sweden have published recommendations for doctors 
about the medication of the elderly (Socialstyrelsen 2003). The most widely used and updated criteria are 
the Beers criteria (Beers et al. 1991; Beers et al. 1997; Fick et al. 2003). These criteria were created in 
Canada using Delphi techniques involving a panel of nationally recognized experts. The Beers criteria 
take into account evidence of the efficacy of the medication for the elderly, possible side effects, the 
availability of safer alternative medication, and factors related to certain diagnoses or conditions. The 
Beers criteria categorize a number of drugs with anticholinergic properties as inappropriate. Cognitive 
decline is one of the most harmful side effects of these drugs, which understandably renders persons with 
dementia especially vulnerable (Ancelin et al. 2006).
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3.4.2.3 Prevalence of inappropriate medication use among the elderly
The use of PIDs has been the focus of considerable study. Depending on the study sample and cultural 
context, the administration of PIDs among home-dwelling patients has ranged from 12.5% to 41.1% 
(Stuck et al. 1994; Willcox et al. 1994; Golden et al. 1999; Piecoro et al. 2000; Zhan et al. 2001; Pitkälä 
et al. 2002; Stuart et al. 2003; Curtis et al. 2004; Fialova et al. 2005). In nursing homes, the respective 
values have ranged from 12% to 50% (Beers et al. 1992; Williams et al. 1995; Spore et al. 1997; Aparasu 
et al. 2000; Dhalla et al. 2002; Gray et al. 2003; Lau et al. 2004). Among elderly in-hospital patients, PID 
use has varied between 15% and 29% (Onder et al. 2003; Onder et al. 2005), and among emergency units, 
between 11% and 13% (Chin et al. 1999; Caterino et al. 2004). Most of these investigators have modified 
the Beers criteria, which makes comparison of these studies difficult. 
3.4.2.4 Prognosis of inappropriate medication use among the elderly
While several studies have examined the associations and predictors of PID use (Stuck et al. 1994; 
Piecoro et al. 2000; Beers et al. 1992;Williams et al. 1995;Dhalla et al. 2002; Gray et al. 2003; Lau et al. 
2004; Aparasu et al. 2000; Onder et al. 2003; Onder et al. 2005; Chin et al. 1999; Caterino et al. 2004; Fu 
et al. 2004; Hanlon et al. 2000; Lane et al. 2004; Simon et al. 2005), few studies have explored the 
prognosis of PID use (Onder et al. 2005; Fu et al. 2004; Hanlon et al. 2002; Fillenbaum et al. 2004; Perri 
et al. 2005; Klarin et al. 2005). Only one study has shown an increase in mortality attributable to PID use 
(Lau et al. 2005), while others have reported no such impact (Onder et al. 2005; Hanlon et al. 2002; Klarin 
et al. 2005). Three studies have examined the impact of PID use among in-hospital patients (Onder et al. 
2005; Perri et al. 2005; Lau et al. 2005), showing controversial results: hospitalization and mortality 
increased in the US study (Lau et al. 2005), whereas an Italian study showed no differences in mortality, 
adverse reactions or length of hospital stay (Onder et al. 2005), and yet another study from the US showed 
an increase in one of the three adverse health outcomes: hospitalization, visits to the emergency room, or 
death (Perri et al. 2005) (Table 1). To date, no studies have examined the prognosis of PID use among 
persons with dementia.
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Criteria PID % Prognostic outcomes
Home-dwelling patients




36 Beers 1997 modified 21.0 Mortality +-
Functional status -









36 Beers 1997 27.9 Use of outpatient services +
Hospitalization +
Nursing home entry +




36 Beers 1997 modified, 
Canadian criteria, and 





Nursing home and in-hospital patients




5 Beers 1997 46.5 One of the adverse health 
outcomes (hospitalization,
emergency department visits 
or death) + 








Length of hospital stay +-








+ = significant increase
+- = no significant changes
- = significant decrease
p < 0.05
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3.4.3 Antipsychotic drugs and dementia
3.4.3.1 Use of antipsychotics in the treatment of persons with dementia 
Persons with dementia often exhibit behavioral symptoms, which can vary as the disease progresses (Sink 
et al. 2005). Such disorders are an important cause of permanent institutionalization (Koponen and 
Saarela, 2006). Antipsychotic medication is widely used among elderly long-term care patients, mainly 
to manage the behavioral disorders of dementia (Phillips et al. 2003; Pitkälä et al. 2004). The antipsychotic 
drug use has varied from 15% to 42% among nursing home patients (Avorn et al. 1995;Gurwitz et al. 
2000; Llorente et al. 1998; Lasser et al. 1998; Liperoti et al. 2003; McGrath et al. 1996; Oborne et al. 
2002; Ford et al. 2002; vanDijk et al. 2000; Ruths et al. 2001; Sorensen et al. 2001; Holmquist et al. 2003; 
Hosia-Randell et al. 2005; Snowdon et al. 1999; Draper et al. 2001) (Table 2). This has been considered 
enough of a problem that the US government passed the Omnibus Reconciliation Act (OBRA-87), 
legislation designed to restrict the over-prescription of these drugs to the elderly (Snowden et al. 1998). 
When researchers estimated the current practice in the UK from 1997 to 1998, only 17.8% of antipsychotic 
prescriptions were considered appropriate (Oborne et al. 2002). Studies of the incidence of antipsychotic 
use among patients with dementia are scarce. In institutions in Finland, the use of antipsychotic 
medication among patients with dementia is high: up to 55% (Pitkälä et al. 2004).The corresponding 
value in Singapore is 45% (Mamun et al. 2003), and in the US, 52% (Lasser and Sunderland 1998).
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Table 2. Use of antipsychotic drugs among nursing home and hospital patients with or without dementia, 
according to earlier studies
Authors N Country Antipsychotic use 
Avorn et al, 1995 1106 USA 25%
McGrath and Jackson, 1996 909 UK 24%
Llorente et al, 1998 1573 USA 18%
Lasser and Sunderland, 1998 298 USA 42%
Snowdon, 1999 1975 Australia 23%
Gurwitz et al, 2000 2916 USA 17%
van Dijk et al, 2000 2355 Netherlands 35%
Ruths et al, 2001 1552 Norway 23%
Sorensen et al, 2001 288 Denmark 21%
Draper et al, 2001 647 Australia 21%




Oborne et al, 2002 934 UK 25%
Liperoti et al, 2003 139714 USA 15%
Mamun et al., 2003 384 Singapore 24%
Holmquist et al , 2003 175 Sweden 16%
Raivio et al, 2005 425 Finland 48%
Hosia-Randell et al, 2005 1987 Finland 43%
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3.4.3.2 Risks of the use of atypical antipsychotics
Since 2002, a lively discussion of the risks of atypical antipsychotic drugs in patients with dementia has 
taken place as several studies have shown increased stroke and death risks related to such drugs 
(Wooltorton et al. 2002; Wooltorton et al. 2004; Singh and Wooltorton 2005; Schneider et al. 2005). Odd 
ratios concerning the risks for adverse cardiovascular events range from 2 to 4, based on partly 
unpublished data from pooled analyses of clinical nursing home and outpatient trials (11 nursing home, 
4 outpatient trials) of risperidone and olanzapine for residents with dementia (Medicines and Healthcare 
Products Regulatory Agency 2004; Racoosin et al. 2004). Becauce of these risks, Health Canada, the US 
Food and Drug Administration, and UK Committee on the Safety of Medicines have warned clinicians 
about the stroke risks related to the use of atypical antipsychotics (Schneider et al. 2005; Gill et al. 
2005).
According to a meta-analysis of 15 trials, 9 of which remain unpublished, death occurred more often 
among patients using atypical antipsychotic medication than among non-users (3.5% vs. 2.3%, 
respectively, OR 1.54, 95% CI 1.06-2.23; p=0.02). All of these studies lasted only 10 to 12 weeks. In 
conclusion, the meta-analysis showed the association of a slightly higher risk for death among users of 
atypical antipsychotics than among those with placebo (Schneider et al. 2005). These findings lead to the 
possibility of an increase in the use of older, conventional antipsychotics instead of newer, atypical drugs 
in the treatment of behavioral symptoms of persons with dementia. 
In a one-year prospective follow-up design, Suh and Shah (2005) compared the mortality risk of 273 
nursing home patients with dementia using any kind of antipsychotic to that of non-users; their results 
showed a surprisingly higher risk of mortality among non-users (RR 1.3, 95 %CI 1.1-1.4).
Comparing the risks of users of atypical or conventional antipsychotics has yielded mixed results. Three 
large-scale retrospective studies have examined stroke risk; all of them concluded that users of 
conventional antipsychotics showed no higher risk for stroke than did users of atypical ones (Gill et al. 
2005; Herrmann et al. 2004; Finkel et al. 2005). Two studies lasting from 180 days to two years examined 
mortality risk as a whole among elderly patients (Nasrallah et al. 2004; Wang et al. 2005); both studies 
found higher mortality rates among users of older, conventional antipsychotics. However, these studies 
did not examine persons with dementia as a special subgroup nor did they compare users to non-users.
33
3.4.3.3 Effectiveness of antipsychotics in the treatment of behavioral 
symptoms of dementia
Until now, the benefits of atypical antipsychotics to treat psychosis, agitation, or aggression in patients 
with AD, have remained uncertain. According to a review by Sink et al. (2005), most drug therapies lack 
evidence of effectiveness in the care of behavioral symptoms, whereas atypical antipsychotics show the 
strongest evidence (Sink et al. 2005). In a recent multi-center, double-blind, placebo-controlled US trial 
by Schneider et al. (2005), 421 home-dwelling patients with AD were examined while undergoing 
treatment for psychosis, aggression, or agitation with olanzapine, quetiapine, risperidone, or placebo. The 
follow-up period lasted up to 36 weeks, and the main outcomes showed that the most influential factors 
were time from initial treatment to the discontinuation of it for any reason and the number of patients 
showing at least minimal improvement on the Clinical Global Impression of Change scale at 12 weeks. 
This study found no advantage in the efficacy of atypical antipsychotics for the treatment of outpatients 
with AD exhibiting psychosis, aggression or agitation, which could offset the adverse effects of these 
drugs (Schneider et al. 2005).
In conclusion, clinicians treating elderly persons with dementia express controversy over the hazards and 
efficacy of medication treatment for behavioral disorders, which are the most challenging symptoms to 
manage, and which are among the most important reasons for institutionalization. The warnings given to 
clinicians cannot properly be taken into account in practice, and some have questioned whether the 
agitation itself, rather than the use of atypical antipsychotics, leads to increased mortality (Schneiderman 
2005; Karlawish 2006).
3.4.4 Use of and need for services among AD families 
3.4.4.1 Use of the social services among care-giving  
families of persons with AD
Spousal caregivers of persons with AD are usually very committed to their care-giving and feel that they 
have a lifelong duty to care for their spouse rather than to entrust his/her care to a nursing home (Ganzer 
and England 1994; Saarenheimo 2007). Earlier population-based studies indicate that neuropsychiatric 
symptoms such as depression, agitation, paranoid thoughts, hallucinations, and wandering, occur 
frequently in patients with AD: 75% of patients with dementia and 43% of patients with mild cognitive 
impairment suffer from such symptoms (Lyketsos et al. 2002). Many studies have identified the caregiver’s 
heavy burden, stress, and mental strain as well as his/her need for support and services (Mittelman et al. 
1996; Dello Buono et al. 1999; Eloniemi-Sulkava et al. 2002). Nevertheless, the families of dementia 
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patients are often reluctant to use services offered (Toseland 2002; Zarit and Leitsch 2001; Ganzer and 
England 1994; Dello Buono et al. 1999; Nankervis et al. 1997).
Officially organized services are typically taken into consideration when informal services, usually 
provided by the closest, are no longer available or only in crisis situations (Nankervis 1997). Families may 
have insufficient information about services available (Dello Buono et al. 1999; Toseland et al. 2002), and 
may previously have experienced disappointment with, for example, health care workers inadequately 
trained to cope with patients with AD; such health care workers are equally puzzled such families’ failure 
to accept the services offered them (Dello Buono 1999; Zarit and Leitsch 2001). Such families, who very 
highly value autonomy, privacy, and dignity in their very stressful situations, seek a more flexible service 
system with the potential to influence the services offered them (Malone Beach et al. 1992; Nankervis 
1997; Saarenheimo 2007).
3.4.4.2 The Finnish social service system
In Finland, both local and state authorities officially offer different social services to such families. Local 
authorities offer financial support to caregivers on the basis of the application submitted. Skilled home 
nursing and other practical daily services fall under the responsibility of the local authorities. Support 
from the state is administered by the Social Insurance Institution under the authority of the Ministry of 
Social Care and Health. This support is provided on the basis of an application for reimbursement of AD 
medication (donepezil, galantamine, rivastigmine, and memantine) from a special caring pension for the 
person with AD who requires extra help, guidance, or supervision, and who may also incur high costs 
because of the disease. In addition to these, various organizations, such as chemists, tax authorities, 
police, private medical centers, and administrative councils, handle a range of other services (Eloniemi-
Sulkava et al. 2006) (Figure 2).
Because the long-term use of medication for AD is costly for the family, most individuals exercise their 
legal right to receive compensation for drug costs from the state. To apply for such compensation, every 
patient must submit a statement from a specialist doctor (neurologist, geriatrician, or psychogeriatrician) 
to the Social Insurance Institution. Reimbursement of drug costs is approved only if AD has been properly 
diagnosed. Thus, each patient must undergo proper diagnostics, which include neuropsychological tests 
or at least the Mini Mental State Examination, laboratory tests, and a CT or MRI scan of the brain in 
addition to proper anamnesis of the patient and of someone close to him/her as well as a physical 
examination by a doctor.
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3.4.4.3 Impact of the unmet needs of care-giving families on  
persons with AD
Unmet needs and dissatisfaction with services are common (Dello Buono et al. 1999; Nankervis et al. 
1997), more so among families caring for dementia patients than among caregivers of non-demented 
patients (Philp et al. 1995). In the EUROCARE cross-national survey (N = 280), formal home care 
received or financial support had no impact on caregivers’ burden (Schneider et al. 1999). Only a few 
large-scale studies have examined the impact of unmet needs on families with Alzheimer patients. A US 
study of 4 761 families with dementia sufferers suggested that early utilization of community-based 
services was cost-effective and delayed institutionalization (Gaugler et al. 2005a). An 18-month 
longitudinal study of 5 831 families with dementia sufferers found that unmet needs were associated with 
an increase in nursing home placements, deaths and lack of follow-up visits (Gaugler et al. 2005b). To 
date, no large-scale epidemiological studies have investigated the unmet needs of specific services among 
care-giving families of persons with AD.
3.4.5 Guardianship and use of financial powers of  
attorney among persons with AD
3.4.5.1 Legal capacity and AD
Dementive disorders lead to a decline in cognitive capacity. Caregivers and those closest to the dementia 
sufferer – usually inadvertently – assume responsibility for financial and other legal affairs even before 
diagnosis. The patient’s weakening cognitive capacity is not an all-or-nothing situation. In the mild stages 
of dementia, a person is usually able to understand the meaning and consequences of legal matters. In the 
moderate stages, however, the decline begins such that most persons in the severe stages of dementia are 
considered incapable of decision-making in legal matters (Mäki-Petäjä-Leinonen 2003).
Legislation varies among the different European countries. According to Alzheimer Europe, a European 
association of AD, Austria, Germany, Denmark, and Finland are regarded as having sufficient legislative 
flexibility to accommodate changes in patients’ needs. Guardianship laws in Finland and Denmark 
emphasize self-determination and the need to respect the wishes of the incapable person, a view which 
Alzheimer Europe also recommends (Gove and Georges 2001).
Incapacity in decision-making has received relatively little empirical study as lawyers mostly concentrate 
on interpretations of law. One US study examined this issue among nursing home patients and found that 
incapacity in decision-making is quite high (44-69%) (Kim et al. 2002). Most care-giving families lack 
36
sufficient information on how to appraise these problems in their everyday life (Wadley et al. 2003). 
Families expect the doctor to take the initiative (Markson et al. 1997). Guidelines for such medico-legal 
situations currently exist in the US (Overman and Stoudemire 1988) and UK (Lord Chancellor’s 
Department 2003; British Medical Association and Law Society 2004). Finland, however, as yet has no 
specific guidelines for such matters.
3.4.5.2 Guardianship and AD
AD is the most common reason for guardianship orders (Wattis et al. 1990). Guardianship is usually 
needed to handle financial arrangements, but sometimes decisions concerning a patient’s place of 
residence while the disease develops as well as specific treatment decisions, such as end-of-life care, can 
be notable (Caralis 1994; Kane 2001; Wattis et al. 1990). Guardianship is often necessary when a patient 
loses cognitive capacity and refuses help (Wattis et al. 1990).
One US study has examined the use of guardianship by interviewing caregivers of nursing home patients. 
The researchers concluded that most of the caregivers were familiar with the term guardianship, and 
nearly a quarter (23.6%) of nursing home residents had a court-appointed guardian (Janowsky et al. 
1993). The largest and to date the only empirical study on the use of guardianship among home-dwellers 
with AD is an Italian study of a sample of 100 patients. In this sample, none of the patients with mild-
stage dementia had a guardian, while 11.5% of those with moderate-stage, and 10.4% of those with 
severe-stage dementia did. The researchers recommended national guidelines and emphasized the 
importance of discussions with a doctor as soon as possible after the diagnosis of dementia (Ruggieri et 
al. 2003). No other earlier large-scale studies exist on the prevalence of guardianship use or on factors 
related to the need for guardianship.
3.4.5.3 Financial powers of attorney and AD
One of the most sophisticated way to handle financial matters for a person with AD is with a financial 
power of attorney, when made by the person him/herself prior to the decline in his/her legal competency. 
This method is also often recommended among lawyers because guardianship is a much more 
comprehensive form of control and is difficult to revoke (Mäki-Petäjä-Leinonen 2003). Nevertheless, 
enacting financial powers of attorney is difficult arrangement with related conflicts inside the family or 
when the person with dementia distrusts those close to her/him. Although paranoia may sometimes arise, 
the financial exploitation of elderly persons with dementia does occur, which should be taken into account 
when considering the sufficiency of powers of attorney. In such situations, including when a person lives 
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alone with no close ones to care for her/him anyhow, financial powers of attorney may not be a good 
alternative and such a person may require a court-appointed guardian. In the literature contains no 
empirical clinical studies on the use of financial powers of attorney among persons with dementia.
In Finland, the economic affairs of a person with dementia can in the future be handled with Enduring 
Powers of Attorney. Then, a person with dementia can arrange his/her financial or other affairs beforehand 
and, in addition to designating a trusted person, decide on how his/her affairs should be handled when s/he 
is no longer capable of handling them her/himself. Act of Enduring Powers off Attorney comes into force 
at 1st November 2007 in Finland.
In conclusion, a decline in decision-making capacity is one symptom of AD, and most guardianship 
arrangements are made for persons with dementia. Empirical studies on this topic are rare, however, and 
to date only one rather small Italian study (Ruggieri et al. 2003) has examined the prevalence of 
guardianship use among home-dwelling person with AD.
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4 AImS OF THE PRESENT STUDy
The primary aim of this study was to explore pitfalls in the treatment and care of persons with dementia 
in order to identify possible new solutions or ways to approach these clinically important matters.
The specific aims were:
1. To study the impact of weight-bearing restrictions on the rehabilitation outcome of elderly hip fracture 
patients with and without dementia. (Study I)
2. To examine the use of inappropriate drugs (according to the Beers criteria) among institutionalized 
elderly patients with and without dementia, and their impact on two-year mortality and the use of 
health services. (Study II)
3. To investigate the impact of atypical and conventional antipsychotics on mortality and on hospital 
admissions among elderly institutionalized patients with dementia over a two-year follow-up period, 
and to compare their prognosis to that of non-users. (Study III)
4. To explore how the spousal caregivers of home-dwelling dementia patients receive support and 
services and how these services meet the caregivers’ needs. (Study IV)
5. To examine the prevalence of court-appointed guardians or financial powers of attorney among 
persons with AD or both, and the factors associated with them as well as whether such persons with 
AD and their spousal caregivers discussed or felt the need to discuss such issues with a doctor or both. 
(Study V)
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5 THE PRESENT STUDy
5.1 Subjects and methods
5.1.1 Hip fracture patient sample in the Päijät-Häme area (Study I)
The data for Study I, which explores the impact of weight-bearing restrictions on hip fracture patients, 
were collected in the Päijät- Häme area of Southern Finland. All the patients (N = 98) underwent surgery 
at the Päijät-Häme Central Hospital and were transferred to the local Lahti City Hospital for rehabilitation 
between 1998 and 1999. Patients from long-term care, provided they had a hip fracture and underwent 
rehabilitation in the same hospital, were also included. Totally bedridden patients were excluded. All 
patients were able to walk independently with or without aids prior to the hip fracture.
Medical records were used in collecting information on patient characteristics and their outcome data. 
Those with dementia (N = 36) were sub-analyzed. Dementia was defined as performing poorly (< 24/30 
points) on the Mini Mental State Examination (Folstein et al. 1975, Tombaug et al. 1992). We excluded 
those lacking an MMSE test score and those with delirium or other serious, acute illnesses causing acute 
cognitive disorders. Independent walking ability with or without aids within six weeks and the mean 
number of active rehabilitation days with a consulting physiotherapist served as the main outcome 
measures.
5.1.2 Sample of institutionalized elderly patients in  
Helsinki (Studies II and III) 
5.1.2.1 Participants
Study II, which examined the prevalence and prognostic significance of inappropriate medication use 
(according to the Beers criteria) in Finland, and Study III, which examined the prognostic significance of 
antipsychotics, both comprised a sample of patients from seven acute wards of two geriatric hospitals 
(Laakso hospital and Kivelä hospital, N = 230) and from thirteen wards of seven nursing homes (Apollo, 
Lilla Apollo, Mariankoti, Pikku-Maria, Minervakoti, Villa Näset, and Villa Kälkestad, N = 195) in 
Helsinki (total N = 425). The mean age of the patients was 86 years. Detailed interviews and observations 
of the patients were carried out in this two-year longitudinal study, which was originally designed to 
investigate symptoms of delirium in long-term care among the elderly (Laurila et al. 2003). All 
consecutively admitted patients in acute geriatric hospitals (November 1999 to March 2000) and all 
residents of nursing homes (November 1999 to October 2000) during the study period underwent 
assessment. Coma and age < 70 years were the only exclusion criteria. 
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5.1.2.2 Examinations
Examination comprised an extensive patient interview, various mental tests, and data were collected from 
medical records and nurses’ notes as well as from caregivers’ and nurses’ interviews conducted by two 
geriatricians (Jouko Laurila and Kaisu Pitkälä) in acute geriatric wards and by ward nurses in nursing 
homes (Laurila et al. 2003). The assessment included the patient’s history, a physical examination, and a 
determination of mental status with MMSE (Folstein et al. 1975), the digit span test, and parts of the 
Wechsler adult intelligence scale (Wechsler 1958) suitable for assessing abstract thinking, comprehension, 
judgment, and problem-solving, the Clinical Dementia Rating Scale (CDR) (Charlson et al. 1987), and 
DSM-IV criteria for delirium and dementia (American Psychiatric Association 1994). To confirm the 
patients’ pre-assessment cognitive status, comorbidities, symptoms, and signs, all of the patients’caregivers 
were interviewed. Medical records provided data on demographic variables, place of residence, and 
comorbidities. We also used the Charlson comorbidity index, a weighted index that takes into account the 
number and severity of comorbid conditions (Hughes et al. 1982) and assessed dependence in activities 
of daily living (ADL) with the CDR class “Personal care”: CDR class 1 or higher (“Requiring at least 
prompting or assistance in dressing, hygiene, managing personal effects, or requiring much help with 
personal care, often involving incontinence”) was defined as dependence in ADL (Charlson et al. 1987). 
The caregivers of all of the patients were interviewed in order to estimate the patients’ status according to 
the CDR.
5.1.2.3 Definition of dementia
Global assessment of dementia (definite or highly probable) among patients in acute geriatric wards and 
in nursing homes was based on consensus among three geriatricians (Jouko Laurila, Kaisu Pitkälä, Timo 
Strandberg) with the aid of all the information gathered. Prior diagnoses of dementia and the adequacy of 
their diagnostics were assessed from medical records. The CDR and the operationalized dementia criteria 
(according to the DSM-IV) served to support the diagnoses of dementia. The nurses or caregivers or both 
were interviewed with regard to the patients’ previous cognitive performance and physical functioning. 
Results of the brain CT/MRI scan (36% of the patients), EEG (3% of the patients), and previous MMSE 
scores (32.5% of the patients) – if any of these three tests were performed – were registered.
5.1.2.4 Diagnosis of delirium and use of restraints
Delirium was explored in detailed examinations of all present symptoms and signs at the time of the 
investigation, and was operationalized using the delirium criteria of the Diagnostic and Statistical Manual 
of Mental Disorders IV (DSM-IV) (American Psychiatric Asssociation 1994). Medical records provided 
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data on the use of restraints, meaning whether a patient had been physically restrained in a bed or geriatric 
chair during the two weeks prior to assessment. 
5.1.2.5 Mortality and hospital admissions
Central registers were used for gathering the mortality and death dates at the end of 2002 such that each 
subject had a two-year follow-up period. Medical records from all area hospitals provided data on 
admissions to acute geriatric hospitals based on the index hospitalization and the days spent there after 
the assessment. The acute geriatric hospitals in this study serve a population of about 200 000 inhabitants, 
and mainly treat elderly subjects with acute illnesses and in need of rehabilitation. Residents from nursing 
homes may also receive temporarily treatment in these hospitals for various acute illnesses.
5.1.2.6 Study II
Medical records were used to estimate the use of medication (Pitkälä et al. 2004). We used the Beers 
criteria 1997 for coding medications because these criteria were available and familiar to clinicians at the 
time, but used the criteria 2003 for examination; we examined only those medications in regular daily use, 
and used only diagnosis-independent Beers criteria rather than criteria that included drug-disease 
interactions. For safety reasons, several drugs in the Beers criteria were unavailable in Finland between 
1999 and 2000, namely because more effective drugs were available. Those drugs included phenylbutazone, 
pentazocine, trimethobenzamide, methocarbamol, carisoprodol, chlorzoxazone, metaxalone, 
cyclobenzaprine, flurazepam, chlorpropamide, dicyclomine, hyoscyamine, propantheline, belladonna 
alkaloids, chlorpheniramine, difenhydramine, cyproheptadine, promethazine, tripelennamine, 
dexchlorpheniramine, meperidine, and ticlopidine. Treatment with difenhydramine requires special 
permission, which makes its use in Finland quite rare. Tioridazine, which the Beers criteria (2003) list as 
a PID, is no longer available in Finland.
5.1.2.7 Study III
Data on medication use were collected from medical records at baseline between 1999 and 2000 (Pitkälä 
et al. 2004). The baseline examination of drugs was cross-sectional, and no data were available on the 
withdrawal or subsequent re-administration of medications during the two-year follow-up period. In 
Study III, we examined only those antipsychotics that were in regular use. Antipsychotics were coded and 
classified as follows: atypical antipsychotics included risperidone and olanzapine. None of these elderly 
patients used quetiapine, aripiprazole, ziprasidone, or clozapine between 1999 and 2000. Haloperidol, 
levomepromazine, melperone, sulpiride, zuclopenthixol, flupentixole, perphenazine, pericyazine, 
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promazine, chlorpromazine, and chlorprothixene were classified as conventional antipsychotics. One 
patient taking both atypical and conventional antipsychotic medication was excluded from the analyses. 
Our sample then comprised 424 subjects, 254 of whom had dementia.
5.1.3 Sample of the caregivers of patients with AD in  
Finland (Studies IV and V)
5.1.3.1 Participants
The Social Insurance Institution of Finland maintains a register of Alzheimer drug users from which we 
collected our random sample (N = 1 943). Each person with AD in that register had been approved for 
compensation of AD drugs and had a spouse living at the same address. A postal questionnaire was sent 
to such spouses living in five urban and non-urban regions (Helsinki, Tampere, Central Finland, Northern 
Karelia, and Lapland and Northern Osthrobothnia) representative of various parts of Finland. Our study 
used no age criteria.
5.1.3.2 The Finnish drug compensation strategy for persons with AD
The Ministry of Social Care and Health in Finland has obligated the Social Insurance Institution to 
consider all grounds for AD drug (donepezil, galantamine, rivastigmine, and memantine) compensation. 
Most individuals apply for compensation from the state to cover the high costs of these drugs. Each 
application must include a statement from a specialist doctor (a neurologist, geriatrician, or 
psychogeriatrician), and financial reimbursement is approved only if AD has been properly diagnosed. 
Thus, each patient must undergo diagnostics, which include neuropsychological tests or at least the Mini 
Mental State Examination, laboratory tests and a CT or MRI scan of the brain.
5.1.3.3 Sample of the spousal caregivers of persons with AD
Mortality registers served to remove participants no longer living (N = 77), and two couples who, 
according to current address information, lived separately (Figure 3). Questionnaires were sent in 
September 2005 (Appendix 1) and were resent in November 2005 to those spouses who had not 
responded. In all, 77% (N = 1 434/1 866) returned the questionnaire. Of these, 1 214 spouses identified 
themselves as the primary caregiver of the spouse with AD. Of those who did not consider themselves 
caregivers (N = 220), a majority had already admitted their spouse to permanent institutional care (N = 
172) (Figure 4). Because the caregivers were also old and sick, 15 potential caregivers had themselves 
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1 434 caregivers responded (76.8%) 
1 214 caregivers identified themselves as the primary 
caregiver of the person with AD 
-172 persons with AD were in permanent 
institutional care 
-15 spouses were in permanent institutional 
care
-4 couples lived separately 
-29 couples lived together, but the spouse did 
not identify him/herself as a caregiver 
-42 persons with AD were deceased
-33 caregivers were deceased 
-2 couples lived separately 
1 943 postal questionnaires sent to a random sample of persons 
receiving financial compensation for AD medication 
1 866 potential respondants 
Figure 3. Data collection from the postal survey of Finnish spousal caregivers of persons with Alzheimer’s 
Disease, autumn 2005
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been admitted to permanent institutional care. Four couples announced that they lived separately. Only a 
minority of possible caregivers having a spouse with AD at home (N = 29) failed to identify themselves 
in such a role; most of these (N = 27) were in even poorer health than the person with AD.
5.1.3.4 The questionnaire
Our questionnaire inquired about demographic variables, the physical and psychological symptoms of the 
spouse with dementia, the support and services received by the family from the official service system, 
and the caregivers’ subjective needs and satisfaction with these services (Appendix 1). To ensure that our 
questions were easy to understand, the questionnaire was piloted with ten elderly spousal caregivers. 
Several large scale epidemiological surveys of the elderly had previously validated many of the questions 
in our questionnaire (Pitkälä et al. 2001; Routasalo et al. 2006; Savikko et al. 2005). A lawyer specializing 
in matters relating to people with dementia examined those questions inquiring about the use of and need 
for legal advice. All the spouses were offered the possibility to phone one geriatrician (MR) if they had a 
question or concern about the questionnaire. This phone call service was available from September to 
December 2005, the end of the data collection period.
The demographic variables consisted of questions concerning both the caregiver and his/her spouse: their 
age, gender, duration of their marriage, education, and income. Answers to questions about the subjective 
health of the caregiver were divided into two categories: 1) good (subjective health good or fairly good) 
or 2) poor (subjective health poor or fairly poor). The time from the first symptoms of impaired memory 
of the spouse with AD was inquired with the question “In your opinion, when did your spouse’s first 
symptoms of memory impairment or dementia begin to appear?” with the following alternatives: 1) under 
one year, 2) one to two years ago, 3) three to four years ago, and 4) five or more years ago. These responses 
were then categorized into two groups: less than two years ago (responses 1-2) and more than two years 
ago (responses 3-4). Physical functioning was inquired with “What is your spouse’s capability in daily 
activities?” with the following response choices: 1) very good, 2) good, 3) moderate, 4) poor, 5) very poor. 
These responses were then categorized into the following two groups: good to moderate (responses 1-3) 
and poor (responses 4-5).
The mobility of the spouse with AD was inquired by asking whether he/she was able to walk indoors 
without difficulty; the answers were categorized as “able to walk indoors without aid” (1 = yes) and 
“requires aid when walking indoors” (2 = no, requires a stick or walking aid; 3 = no, requires the aid of 
another person, and 4 = no, cannot walk at all). The incontinence of the spouse with AD was inquired with 
the question “Does your spouse experience urinary or bowel incontinence?” with a yes/no option. The 
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need for a caregiver’s assistance and continuous presence was inquired with the question “Does the care 
of your spouse require your continuous presence?” with a yes/no option. Questions about hallucinations, 
depression, and the agitation of the spouse with AD were drawn from the Neuropsychiatric Inventory 
(NPI) (Cummings et al. 1994) with yes/no answers. 
The need for a caregiver’s assistance and continuous presence was inquired with the question “Does the 
care of your spouse require your continuous presence?” with a yes/no option. Difficulties with cooperation 
were inquired with “Do you encounter situations when your spouse refuses to cooperate or does not 
accept help?” with answers yes/no. Strain in care-giving was inquired with two questions “Do you 
consider care-giving mentally/physically demanding work?” with a yes/no answer. Medico-legal issues, 
such as financial powers of attorney and the use of legal guardians and discussions, or need for them, with 
a doctor, were inquired with a question requiring a yes/no answer. The use of various official services in 
Finland and the subjective need for them were inquired with yes/no questions. We also asked whether the 
caregivers found it easy to obtain information about available services. Finally, the caregivers’ satisfaction 
with available services and their ability to influence what services they received were inquired with yes/no 
questions.
5.1.3.5 Official services for caregiving families
In Finland, caregivers who devote several hours of work to daily care-giving are legally entitled to 
financial support from the community. Families must apply for this support, however, but after submitting 
an application, a social nurse carries out a home-visit and evaluation. Before any official services are 
provided for the family, a social or health care worker must approve their need beforehand. The communal 
service system offers a wide range of services (skilled home nursing, domestic help, meals on wheels, 
physiotherapy, day care, respite care, etc.). Communities also offer transport services if using public 
transportation is impossible or too difficult for the disabled person. Of course, communal services carry 
a charge, which depends on the income of the care recipient. Various technical devices are free of charge. 
Finnish World War II veterans, for example, are eligible for state-funded (free of charge) physiotherapy.
5.1.3.6 Study IV
This cross-sectional survey of a random sample of 1 214 spouses identifying themselves as the primary 
caregiver of their spouse with AD inquired about the symptoms and care needs of the spouse with 
dementia, official services received, remaining unmet needs, and the satisfaction of the caregivers with 
regard to the services offered.
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5.1.3.7 Study V
This study consisted of a cross-sectional examination of 1 214 caregivers of persons with AD, the 
prevalence of their use of court-appointed legal guardians or financial powers of attorney, or both, factors 
related to these, and discussions held with a doctor as well as any unmet need for such discussions.
5.2 Ethical considerations
Study I: As this study examined no additional or new developments in the treatment of patients with hip 
fractures, written informed consent from the patients or relatives was unnecessary. The study was 
approved by the local ethics committees of the Lahti City Hospital and the Päijät-Häme Central 
Hospital.
Studies II and III: After receiving a complete description of the study, each patient provided his/her 
written informed consent. In cases of poor judgement capacity or moderate cognitive impairment (Mini 
Mental State Examination [MMSE] (Folstein et al. 1975) score < 20 points), informed consent was 
obtained from the patient’s closest proxy. The study was approved by the local ethics committee of the 
Helsinki University Hospital. 
Studies IV and V: The cover letter of the questionnaire described the aims of the study to the caregivers, 
who were invited to contact one (MR) of the researchers if they had any questions or concerns about the 
study. The study design and questionnaire were approved by the local ethics committee of the Helsinki 
University Hospital.
5.3 Statistical methods
Study I: The Chi-Square test was used to compare proportions and their differences between groups, and 
the T-test, when comparing means and their differences at baseline. The one-sided Mann-Whitney U-test 
was used to compare median rehabilitation times and their differences.
Study II: Patients with or without dementia were categorized as having PIDs or not. To test for differences 
in the proportions, we used the Chi-Square test and Fisher’s exact test. The Mann-Whitney U-test served 
for non-normally distributed continuous variables. Among users and nonusers of PIDs, the prognosis was 
considered as one and two-year mortality. We used the Chi- Square test to compare the proportions of 
those among PID users who died during the two-year follow-up period to those of non-users. Differences 
between the groups (days spent in acute hospitals and number of hospital admissions) were analyzed with 
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the Mann-Whitney U-test. To determine the independent prognostic significance of inappropriate drug 
use on mortality, we used the Cox proportional hazard model. We then constructed unadjusted Kaplan-
Meyer curves to illustrate the cumulative rate of mortality between the groups during the two-year follow-
up period, and calculated the log-rank test. To determine the effect of PIDs on hospital admissions 
(patients admitted/not admitted to hospital), we used logistic regression analysis with the following 
covariates: age > 85 years, sex, education < 7 years, comorbidity (Charlson Comorbidity Index > 2), 
dementia, placement in a nursing home versus a hospital, number of medications without PIDs, and 
functional impairment (CDR “personal care” ≥ 1).
Study III: We compared the characteristics of the patients, both with and without dementia, with the Chi-
Square test. Patients with dementia were categorized into three groups: those using atypical antipsychotics 
or conventional antipsychotics or both or neither. We used the Chi-Square test to test for differences in 
proportions, and the Kruskal-Wallis test for testing the non-normally distributed continuous variables. To 
study the prognosis of demented patients using atypical or conventional antipsychotics or both and of 
those using neither, we created two endpoints: 1) two-year mortality and 2) hospital admission or death 
(a combined endpoint). We compared the proportions of these groups with the Chi-Square test, and used 
the Cox proportional hazard model to determine the independent prognostic significance of the use of 
atypical or conventional antipsychotics on mortality in comparison to that of non-users. As covariates, we 
used age over 85, gender, delirium, dementia, comorbidity (Charlson index > 2) (Charlson et al. 1987), 
functional impairment (CDR class in personal care > 1) (Hughes et al. 1982), the number of medications, 
and the use of restraints. We constructed unadjusted Kaplan-Meyer curves to illustrate the cumulative rate 
of mortality between the groups during the two-year follow-up period, and calculated the log-rank test. 
Study IV-V: The characteristics of the spouses with AD and their caregivers were cross-tabulated 
according to the caregiver’s gender. To test differences between the categorical variables, we used the Chi-
Square test. The Mann-Whitney U-test and the Kruskall-Wallis test served for non-normally distributed 
variables. 
Data in all studies were analysed with the NCSS for Windows statistical program (www.ncss.com) and P 
values < 0.05 were considered significant.
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6 RESULTS
6.1 Clinical pitfalls in the postoperative rehabilitation  
of hip fractures in persons with AD (I)
The study sample comprised 98 patients with hip fractures who underwent surgery at the Päijät-Häme 
Central Hospital. Postoperative rehabilitation took place at the Lahti City Hospital. Doctors recommended 
postoperative weight-bearing restrictions for 37 patients, mostly after osteosynthesis (33 patients, 89%), 
while only 4 patients (11 %) had endoprothesis (Figure 4). The ean age of the patients was 80.2 years, and 
most of them (72.4 %) were female.
Figure 4. All hip fracture patients according to operation type and restriction orders














The active rehabilitation time was significantly longer among patients with weight-bearing restriction 
than among those allowed to walk normally immediately after surgery. While 84% of patients in the non-
restriction group learned to walk independently in six weeks, less than half of those (41%) in the restricted 
group were able to do so (p < 0.001) (Table 3).
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Mean number of rehabilitation days (range) 53.1 (5 to 142) 38.4 (9 to 102) 0.03 1)







20 (12) 0.93 2)
Deceased within one year (%(N)) 16 (6) 23 (14) 0.42 2)
1) Differences between medians by one-sided Mann-Whitney U-test
2) Differences between proportions by X2 test
Of the 98 patients, 36 met the specified criteria for dementia (MMSE points < 24/30). Their mean age was 
83.5, most were female (N = 30, mean age 83.3), and only 6 were male (mean age 84.6). Most of the 
patients with dementia (81%) were living at home prior to the fracture. After the hip fracture, surgery, and 
rehabilitation, only half of them (56%) could return to live in their own home again, while 44% required 
permanent institutional care.
Of those with dementia, the mean rehabilitation period in the weight-bearing restriction group was 
significantly longer than that of the non-restricted group. Of the 24 in the non-restricted group, 20 learned 
to walk in six weeks, but only 1 of the 12 in the weight-restricted group learned to walk again (p < 0.001) 
(Table 4). The patients’ capacity to walk again had a significant effect on institutionalization and one-year 
mortality in the whole group (Table 5).
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Table 4. Outcome data on patients with dementia according to weight-bearing restrictions after hip 
fracture surgery
Variable Weight-bearing 




Mean rehabilitation time (days (range)) 73.5 (27-142) 45.1 (9-58) 0.03 1)







41.7 (10) 0.64 2)
Deceased within one year (%(N)) 25.0 (3) 20.8 (5) 0.78 2)
1) Differences between medians by one-sided Mann-Whitney U-test
2) Differences between proportions by X2 test
Table 5. Outcome data on all hip fracture patients by their capacity to learn to walk within six weeks after 
hip fracture surgery (N = 98)
Variable Learned to walk  
N = 66









59.4 (19) < 0.001 
Deceased within one year (%(N)) 6.1 (4) 34.4 (11) < 0.001 
1) Differences between proportions by X2 test
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6.2 Possible pitfalls in the use of medication in patients with AD
6.2.1 Use and prognostic significance of inappropriate medication  
among hospital and nursing home patients (II)
According to the geriatricians, 60% (255) of the 425 patients in this sample were demented. The patients 
with dementia were mainly female (85.5% vs 75.9%, p = 0.012), had more comorbidities (Charlson 
comorbidity index > 2, 42.4% vs 30.6%, p = 0.014), and were more dependent on their ADL (CDR 
“personal care” ≥1, 76.9% vs 21.2%, p < 0.001) than were those without dementia. No differences in 
mean age were observed between patients with and without dementia. Most dementia patients suffered 
from severe dementia (mean MMSE 9.9) and 76.9% had a CDR of 2 or 3. Polypharmacy was common, 
since the mean number of medications in the whole population (9.0) was higher among patients without 
dementia than among those with dementia (p = 0.02). Only two patients in the entire population took no 
regular medication.
One third (36.2%) of all patients took at least one PID (according to the Beers criteria, 1997) daily. Most 
(28.7%) took only one, 5.9% two, and 0.9 % three. A total of 36.9% of those with dementia, and 35.3% 
of those without dementia, were on at least one PID. Among those with dementia, no significant 
differences appeared between those with or without PIDs in gender, age, marital status, educational level, 
Charlson comorbidity index, or dependence on ADL. Among the patients without dementia, only the 
mean number of medications was higher among patients on PIDs than among those without. Baseline 
characteristics of patients with dementia appear in Table 6.
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Table 6. Baseline characteristics of patients with dementia and the use of potentially inappropriate drugs 
(PID)
Patients with dementia (N = 255)
%
On inappropriate medication 
(N = 94)
No inappropriate medication
(N = 161) 
P-value1
Females 83.0 87.0 0.38
Age > 85 57.0 61.9 0.44
Education < 7 years 55.3 61.5 0.33








Charlson comorbidity  
index > 22
46.8 39.8 0.27
Dependence on ADL (CDR 
“personal care” ≥ 1)3
76.6 77.0 0.94
1 Differences between users and nonusers of PIDs among patients with dementia tested with the X2 test 
for categorical variables and the Mann-Whitney test for continuous variables
2 Charlson et al. 1987
3 Hughes et al. 1982
SD = Standard deviation
By far the most common inappropriate medication among all patients was temazepam, which, at a dose 
of 20 mg daily, was in wide use as a hypnotic among institutionalized patients. Among patients with 
dementia, the most common PIDs were high-dose temazepam (13.3%), oxybutynin (5.5%), dipyridamol 
(4.3%), and hydroxyzine (3.5%), while among those without dementia, the most common PID was high-
dose temaxepam (14.7%), amitriptyline (4.7%), dipyridamol (4.1%), and oxybutynine (2.9%). No 
differences in the proportions of PIDs were observed among these groups, except for amitriptyline, which 
was significantly more commonly used among patients without dementia (p = 0.011) (Table 7).
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The use of PIDs showed no impact on two-year mortality, acute hospital days, or the number of hospital 
admissions among patients with or without dementia. This result showed no change even when we 
performed another analysis with high-severity PIDs (Beers et al. 1997). The results for patients with 
dementia appear in Table 8. Mortality curves were similar across time among PID users and non-users 
(Figure 6).
We also performed additional analyses to determine whether mortality would differ between PID users (N 
= 175) and non-users (N = 250), according to the latest Beers 2003 criteria (Fick et al. 2003). No 
significant differences were observed between the users (1-year mortality 25.1%, 2-year mortality 48.6%) 
and the non-users (1-year mortality 24.8%, 2-year mortality 45.2%) in our sample. According to the 
Beers criteria (2003), 41.2% of Finnish nursing home and hospital patients received PIDs. 
Figure 6. Survival of users (N = 154) and non-users (N = 271) of PIDs in the whole population during 




















Table 7. Use of inappropriate drugs (according to the Beers criteria fully applied)1 (Beers et al. 1997) 
among those with and without dementia
Medication
% (n)












Little analgesic advantage over 
acetaminophen, yet has the side-
effects of other narcotic drugs
0.6 (1) 0.8 (2) 1.00








sedation, and weakness. 
Effectiveness at doses tolerated by 
the elderly is questionable
2.9 (5) 5.5 (14) 0.24
Amitriptyline Strong anticholinergic and sedating 
properties 4.7 (8) 0.8 (2) 0.011
Doxepin Strong anticholinergic and sedating 
properties 2.4 (4) 1.2 (3) 0.44
Meprobamate Highly addictive and sedating 
anxiolytic
0.59 (1) 0.39 (1) 1.00
Loratzepam > 3 mg, 
oxazepam > 60 mg, 
alprazolam > 2 mg, 
temazepam > 15 mg, 
zolpidem > 5 mg, 
triazolam > 0.25 mg
Due to increased sensitivity to 
benzodiazepines among the elderly, 
smaller doses may be both effective 
and safer
14.7 (25) 13.3 (34) 0.87
Chlordiazepoxide, 
diazepam
Long half-life in the elderly, thus 
producing prolonged sedation and 
increasing risk for falls and 
fractures
1.8 (3) 2.0 (5) 1.00
Disopyramide Potent negative inotrope may 
induce heart failure in the elderly
None 0.39 (1) 1.00
Digoxin over 0,125 
mg
Decreased renal clearance 0.59 (1) 1.2 (3) 0.65
Dipyridamole Orthostatic hypotension. Beneficial 
only in patients with artificial heart 
valves
4.1 (7) 4.3 (11) 0.86
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Highly anticholinergic and 
generally produce substantial toxic 
effects









1.8 (3) 3.5 ( 9) 0.42
Diphenhydramine Potently anticholinergic None None
Hydergine, 
cyclospasmol
Not shown to be effective 0.59 (1) 0.39 (1) 1.00
Iron supplements over 
325 mg
At higher doses, total absorption 
not substantially increased, but 
constipation often occurs
None None
All barbiturates except 
phenobarbital
Barbiturates cause more side-
effects in the elderly than do most 
other sedative or hypnotic drugs 
and are highly addictive
None None
Ticlopidine Not shown to be better than aspirin 
in preventing clotting, but is more 
toxic
None None
1 PIDs unavailable in Finland for safety reasons from 1999 to 2000 (according to the Beers criteria 1997): 
phenylbutazone, pentazocine, trimethobenzamide, methocarbamol, carisoprodol, chlorzoxazone, 
metaxalone, cyclobenzaprine, flurazepam, chlorpropamide, dicyclomine, hyoscyamine, propantheline, 
belladonna alkaloids, chlorpheniramine, difenhydramine, cyproheptadine, promethazine, tripelennamine, 
dexchlorpheniramine, meperidine, and ticlopidine 
2 Differencies between the proportions of PID users among patients with and without dementia tested with 
the X2 test or the Fisher exact test
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Table 8. Two-year mortality, days in institutions, and the use of potentially inappropriate drugs (PIDs) 
among patients with dementia
Patients with dementia (N = 255)
On inappropriate medication 
N = 94
No inappropriate medication 
N = 161
P-value1
Number of days in acute 
hospitals/first year
Mean (SD)
22.2 (32.7) 24.9 (38.6) 0.978







Two-year mortality (%) 43.6 47.8 0.515
1 P values are for differences between users and non-users of PIDs among patients with dementia tested 
with the X2 test for categorical variables and the Mann-Whitney test for continuous variables
In the Cox proportional hazard model, using age > 85 y, gender, education < 7 years, comorbidity 
(Charlson index > 2), dementia, placement in a nursing home vs. hospital, number of medications without 
PIDs, and functional impairment (CDR “personal care” 1 or more) as covariates, the use of inappropriate 
drugs had no prognostic significance for mortality (HR 1.02, 95% CI 0.76-1.37, p = 0.89). Age > 85 (HR 
1.73, 95% CI 1.27-2.36, p < 0.001) increased two-year mortality while patients residing in nursing homes 
had a lower mortality than did hospital patients (HR 0.49, 95% CI 0.35-0.69, p < 0.001). We repeated the 
analysis with the same covariates, but used the number of PIDs as one covariate instead of the use of any 
PID. This also showed no effect on mortality (HR 1.06, 95% CI 0.84-1.34). We performed a logistic 
regression analysis on hospital admission with the same covariates, and the use of PIDs had no impact on 
hospital admission (OR 1.40, 95% CI 0.93-2.11, p = 0.11).
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6.2.2 Prevalence and prognostic significance of the use of antipsychotics 
among hospital and nursing home patients (III)
The mean age of the sample (described previously) was 86 years. One patient was excluded from the 
sample due to his/her use of both conventional and atypical antipsychotic drugs. Thus the sample 
comprised 424 patients, of which 254 suffered from dementia. Both atypical and conventional 
antipsychotics were administered to patients with dementia significantly more often than to those without. 
A larger proportion of the patients with dementia had been physically restrained during the previous two 
weeks (12.2%) than of those without dementia (4.7%) (Table 9). 
Table 9. Use of antipsychotic medication and restraints according to dementia





Users of atypical 
antipsychotics
4.1 11.0 0.011 
Users of conventional 
antipsychotics
17.1 37.4 < 0.001 
Physically restrained during 
previous two weeks
4.7 12.2 0.009 
1 Differences between proportions were tested with the Chi Square test, degrees of freedom 1
About half of the patients with dementia received antipsychotics: 37.4% received conventional, 11% 
atypical antipsychotics, and 51.6% were non-users. The most commonly used conventional neuroleptics 
were melperone (40 users) and haloperidol (30 users); the latter was also the most common antipsychotic 
used “as needed”. Polypharmacy and delirium were significantly more common among patients with 
dementia receiving antipsychotic medication than among non-users (Table 10). The use of 
acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) in this severely demented sample 
(mean MMSE 9.9) was rare in 1999-2000: only 3.1% received these drugs. The use of antipsychotic 
medication had no impact on mortality or on hospital admission or on the combined endpoint of these two 
(Table 10).
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Table 10. Baseline characteristics of the patients with dementia according to their use or non-use of 
antipsychotic medication
Variable Users of conventional 
antipsychotics
(N = 95)







Females (%) 82.1 100.0 84.7 0.058 1 
Age > 85 (%) 57.4 46.4 64.6 0.17 1
Education < 7 years (%) 52.0 54.5 49.1 0.86 1
Widowed (%) 47.2 54.2 60.3 0.16 1
Charlson > 23 (%) 45.3 32.1 42.7 0.47 1
Dependent in ADL- 
functioning4 (%) 
82.1 78.6 72.5 0.24 1
Delirium5 (%) 36.8 25.0 18.3 0.007 1
Physically restrained during 
previous two weeks (%)
12.6 17.9 10.7 0.57 1
Mean number of medications 
(SD)
9.5 (3.2) 9.5 (2.6) 7.4 (3.3) < 0.001 
2
Deceased within 1 year (%) 17.9 14.3 26.7 0.17 1
Deceased within 2 years (%) 45.3 32.1 49.6 0.24 1
Mean number of hospital 
admissions (SD)
0.38 (0.70) 0.54 (0.88) 0.67 (0.87) 0.029 2
Hospitalized or deceased 
within 2 years (%)
58.9 53.6 71.8 0.056 1
Differences between proportions were tested with the 1)Chi Square test, degrees of freedom 2; and 
between means and their differences with the 2)Kruskall-Wallis test, degrees of freedom 2
3) Charlson comorbidity index (Charlson et al. 1987) 
4) Those classified in CDR “personal care” > 1 (Hughes et al. 1982)
5) Delirium according to the DSM-IV criteria (American Psychiatric Association 1994)
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Survival of the users of atypical antipsychotics, of the users of conventional antipsychotics, and of the 
non-users during the two follow-up years appears in the unadjusted Kaplan-Meyer analysis 
(Figure 7). The cumulative mortality of all users of antipsychotics compared to that of non-users appears 
in the Kaplan-Meyer curves (Figure 8). The use of antipsychotic medication had no impact on mortality 
in our sample.
Figure 7. Two-year survival of patients with dementia according to their use of atypical, conventional 
antipsychotics, and non-use.
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Non-users
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Time, days
Log rank test p = 0.195
(Chi Square = 3.27, df 2)
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Figure 8. Two- year survival of patients with dementia according to their use of antipsychotics and non-
use.
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 To clarify which factors had independent prognostic value in mortality at two years, we performed a Cox 
proportional hazard model. By entering age, gender, delirium, high comorbidity (Charlson index > 2), 
functional impairment (CDR class in “personal care” > 1), the use of physical restraints, number of 
medications, and the use of conventional or atypical antipsychotics in the model, and age over 85 years, 
the high number of medications and the use of physical restraints predicted higher mortality at two years 
among these patients with dementia. Surprisingly, the use of atypical antipsychotic agents seemed to 
decrease the mortality risk (HR 0.49 (0.24-0.99), p = 0.047). The effect of conventional antipsychotics 
was non-significant (Table 11).
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Table 11. Selected risk indicators (hazard ratios) for two-year mortality among institutionalized dementia 
patients
HR (CI) Patients with dementia (N = 254)
Mortality risk at 2 years P value
Age > 85 1.65 (1.10-2.48) 0.014 1
Females 1.21 (0.71-2.05) 0.48
Delirium 1.26 (0.84-1.89) 0.27
Charlson > 2 1.09 (0.75-1.60) 0.65
CDR > 1 0.99 (0.64-1.53) 0.95
Use of restraints 1.72 (1.04-2.83) 0.034 3
Number of medications 1.12 (1.05-1.20) < 0.001 2
Use of conventional antipsychotics 0.68 (0.46-1.03) 0.069
Use of atypical antipsychotics 0.49 (0.24-0.99) 0.047




6.3 Pitfalls in services for persons with AD
6.3.1 Officially organized services and their unmet needs (IV)
The caregivers of spouses with AD were old and often sick themselves (mean age 78.2 years), and one 
third (35.1%) had poor subjective health. Male caregivers were older than females (80.2 years vs. 76.7 
years, p < 0.001). As in prior international studies, most of the caregivers were females, but the proportion 
of male caregivers in Finland was also quite high (37%), especially considering the old age of the 
respondents. Marriages were very long among female and male caregivers: 52 and 54 years, respectively. 
Over half of the caregivers and spouses with dementia had received less than seven years of education and 
most families regarded their income as moderate.
Of the spouses with AD, 40% required continuous support from their caregiver (Table 12). Half of them 
suffered symptoms of depression, more than two thirds exhibited symptoms of agitation, and almost half 
(44%) experienced hallucinations. Urinary or bowel incontinence was surprisingly common (46%) 
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among these home-dwelling spouses with AD. One in three was unable to move indoors without aid. Male 
spouses with AD experienced significantly more agitation and urinary or bowel incontinence thank did 
females (Table 12).
Table 12 .Prevalence of symptoms and care needs of Finnish home-dwellers with Alzheimer’s disease 










(N = 1 214)
p 1
Requires aid when walking indoors 33.3 36.2 35.1 0.31
Urinary or bowel incontinence 40.0 48.9 45.6 0.002 
Requires the continuous presence of the 
caregiver
39.3 40.1 39.8 0.77
Symptoms of hallucinations 42.3 44.6 43.8 0.44
Symptoms of depression 51.5 53.7 52.9 0.48
Symptoms of agitation 68.3 73.5 71.6 0.06
1 Differences in proportions between genders were tested with the Chi Square test, df 1
The services these couples most often received included community financial support for the caregiver 
(35.9%), various technical devices (33.4%), physiotherapy for the Alzheimer’s patient (32.4%), and 
respite care in a local nursing home for the care recipient (31.1%) (Table 13). Because half of those with 
AD in our sample were war veterans, 71% of the physiotherapy received was constituted the yearly 
rehabilitation entitlement for World War II veterans, which is set by Finnish law. Only 14% of those with 
AD who were not war veterans had received physiotherapy organized by the community. Skilled home 
nursing and domestic help was rarer than expected: it was offered to only 26% and 15% of the families, 
respectively. Male caregivers were offered more skilled home nursing, domestic help, house cleaning and 
meals-on-wheels, whereas female caregivers were more often offered financial support, physiotherapy, 
transport services, and respite care in a nursing home for the spouse with AD. 
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Table 13. Proportions among female and male caregivers of spouses with Alzheimer’s disease receiving 
official services and having unmet needs, but not receiving the service in question 





(N = 1 214)
p
Skilled home nursing 20.8 35.7 26.3 < 0.001
 - unmet needs 9.7 15.9 11.7 0.008
Domestic help 12.6 18.1 14.6 0.01
 - unmet needs 13.3 19.2 15.4 0.013
House cleaning 26.2 33.1 28.7 0.01
 - unmet needs 39.0 44.3 39.9 0.14
Meals on wheels 16.6 25.1 19.8 < 0.001
 - unmet needs 6.5 15.7 9.6 < 0.001
Physiotherapy for care recipient 37.4 23.9 32.4 < 0.001
 - unmet needs 58.1 54.0 56.4 0.25
Technical devices 33.8 32.9 33.4 0.75
 - unmet needs 11.3 12.2 11.6 0.73
Transport service 34.0 15.1 27.1 < 0.001
 - unmet needs 44.3 32.1 39.1 < 0.001
Day care 19.3 18.4 19.0 0.72
 - unmet needs 30.0 29.3 29.8 0.81
Respite care in a nursing home 33.2 27.6 31.1 0.045
 - unmet needs 22.6 26.1 24.0 0.26
Home respite 8.3 11.2 9.4 0.10
 - unmet needs 39.2 41.2 39.9 0.53
Financial support 38.3 31.8 35.9 0.024
 - unmet needs 50.9 48.7 50.0 0.55
Difference in the proportions between genders were tested with the Chi Square test, df 1
The services most desired by those couples who received none of the services in question included 
physiotherapy for the person with AD (56.4%), community’s financial support for the caregiver (50.0%), 
house cleaning (39.9%), and home respite to provide the caregiver with a few hours of free time (39.9%). 
Of those already receiving such services, 16.1% to 30.8% needed more of the same service (Table 13).
Only half (53.5%) of the caregivers felt that the official services had responded to their needs in a timely 
manner. Only 39.3% of the spousal caregivers were satisfied with the services received. Less than a third 
(29%) of them found it easy to obtain information about available services. The majority of the caregivers 
(69.4%) felt unable to influence the services they received.
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6.3.2 Use of guardianship and financial powers of attorney (V)
The sample was the same as that used in the study of officially organized services. In Finland, the use of 
guardians was rare: only 4.3 % of the entire sample had made such an arrangement. No gender differences 
were found between female and male patients (5.1 vs. 3.8, p = 0.30). Patient- related factors associated 
with the arrangement of guardianship include poor functioning, depression in the patient with AD, 
symptoms of dementia for more than three years, and cooperation difficulties (Table 13). The couple’s 
level of education or income showed no association with the use of guardianship. The need for continuous 
care-giving, symptoms of agitation, and urinary or bowel incontinence did not associate with the use of 
guardians. In contrast to the use of financial powers of attorney, the physical more than the mental strain 
of care-giving was associated with the arrangement of guardianship (Table 14).
Discussing these arrangements with the doctor was quite rare: only 9.9 % of the couples had done so. 
However, the need for such discussion with a doctor was common (47.9%). In most of the cases in which 
guardianship had been arranged, discussion with a doctor had taken place (57.1% vs. 7.6%, p < 0.001) 
and financial powers of attorney had been organized (83.0% vs.35.7%, p < 0.001). More guardianship 
arrangements had been carried out among those who had also arranged financial powers of attorney 
(8.8% vs.1.3%, p < 0.001, Chi Square test, df1).
Table 14. Factors related to the use of guardianship among home-dwellers with Alzheimer’s disease (AD) 
with a spouse caregiver (N = 1 170)
% Guardianship is  
arranged (N = 50)
Guardianship not  
arranged (N = 1 120)
p 1
Poor functioning 77.5 55.8 0.003
Requires continuous care-giving 46.0 39.5 0.36
Depression 67.3 52.3 0.04
Hallucinations 57.1 43.8 0.07
Agitation 75.0 71.9 0.64
Urinary or bowel incontinence 53.1 45.7 0.31
Cooperation difficulties 61.4 45.4 0.04
Heavy mental strain of care-giving 66.0 61.6 0.53
Heavy physical strain of care-giving 44.7 23.2 < 0.001
Symptoms of dementia > 3 years 88.4 76.7 0.012 
1) Differences between proportions were tested with Chi Square test, df 1
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Financial powers of attorney were quite common (37.8%); there were no gender differences between 
female and male patients with AD (35.6% vs. 39.1%, p = 0.23, Chi Square test, df 1). Patient-related 
factors associated with the arrangement of financial powers of attorney include poor functioning, 
hallucinations, and urinary or bowel incontinence. Neither the education of the spouse with AD nor of the 
caregiver or the income of the couple was associated with the use of financial powers of attorney. 
Exhibiting symptoms of dementia for more than three years was associated with the arrangement of 
financial powers of attorney, but the need of continuous care-giving, symptoms of depression in the 
patient with AD, and agitation showed no significance (Table 15). 
Table 15. Factors related to the use of financial powers of attorney among home-dwellers with Alzheimer’s 
disease with a spouse caregiver (N = 1 159)
% Financial powers of 
attorney arranged  
(N = 438)
Financial powers of attorney 
not arranged (N = 721)
p 1)
Poor functioning 65.9 51.1 < 0.001
Requires continuous care-giving
41.3 39.2 0.47
Depression 55.7 51.6 0.19
Hallucinations 48.6 41.2 0.02
Agitation 75.0 70.2 0.08
Urinary or bowel incontinence 52.8 42.0 < 0.001
Cooperation difficulties 54.0 41.7 < 0.001 
Heavy mental strain of care-giving 69.4 57.3 < 0.001 
Heavy physical strain of care-giving 32.4 19.0 < 0.001 
Symptoms of dementia > 3 years 82.7 74.1 < 0.001 
1) Differences between proportions were tested with the Chi Square test, df 1
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7 DISCUSSION
AD is a long-lasting disease which changes the lives not only of the persons developing the disease, but 
of those closest to him/her. AD is one of the most common diseases among the oldest of the elderly, and 
affects about a third of those over 85. As the population ages, the number of persons with dementia has 
been estimated to increase by about 60% until the year 2030 (Viramo and Frey 2006).
From the point of society, AD may also be the most expensive of diseases, with permanent institutional 
care, which almost every person with AD requires sooner or later, comprising the bulk of the treatment 
costs (Viramo and Frey, 2006). Before choosing institutional care, these persons attempt to cope with this 
disease with the help of their caregivers and by using needed services. This thesis identifies certain pitfalls 
in our health care and social service system that may affect such persons during the course of their disease 
(Figure 9).
7.1 Rehabilitation of elderly hip fracture patients
Certain clinical pitfalls can be recognized in the rehabilitation of hip fracture patients with dementia. 
According to our data, the postoperative rehabilitation period is clearly longer among hip fracture patients 
with weight-bearing restrictions than among those who had no such restrictions. Furthermore, difficulties 
in learning to walk were very common among all elderly patients with such restrictions regardless of 
dementia: just under half (41%) learned to walk within six weeks. In addition, weight-bearing restrictions 
seemed especially harmful among patients with dementia: only 1 of the 12 patients could walk after six 
weeks.
The most significant factors predicting mortality and long-term disability among patients with hip 
fracture include age, functional impairment, and comorbidity, and especially dementia (Kennie et al. 
1988; Cameron et al. 1993; Huusko et al. 2000; Jette et al. 1987; Gilchrist et al. 1988; Galvard and 
Samuelsson 1995; Kuokkanen and Korkala 1992; Luethje et al. 1995). Our data are very much in line 
with these results, as almost half (44%) of our patients with dementia and hip fracture required permanent 
hospitalization after rehabilitation even though most of them (81%) were home-dwellers before.
Our sample of patients with hip fracture was retrospective, which means that the patients may not have 
been medically the same at the starting point, which is one limitation of this study. However, our sample 
could be considered a “real-life” geriatric sample. Organizing large-scale randomized clinical trials on 
the effect of weight-bearing restrictions would be impossible for ethical reasons. Secondly, our subgroup 
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of patients with dementia was quite small, and we may have been unable to include all demented patients 
into that analysis, because the definition of dementia was based only on the MMSE scores available in the 
medical records. Those with no tests performed or the frailest ones with delirium or other serious illnesses 
were excluded. However, even in the small group of patients with dementia and with low statistical power, 
we were able to show significant differences in outcomes between those who did and did not have weight-
bearing restrictions. Thirdly, the definition of dementia as having an MMSE score < 24 points may also 
include delirious patients. With such an orthopedic sample of elderly patients, however, systematically 
gathering information for definite dementia diagnosis was impossible, so the information available had to 
MMSE = Mini Mental State Examination
CDR = Clinical Dementia Rating Scale
GDS = Global Deteriorating Scale/Functional Assessment Staging
Figure 9. Certain clinical pitfalls according to stage of Alzheimer’s disease (AD).
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suffice. In addition, studies have shown that a great proportion of those developing delirium suffer from 
poor cognitive reserves and develop dementia in a few years (Rahkonen et al. 2001;Lundström et al. 
2003).
Surgeons do recognize patients with severe dementia, but still find it challenging to recognize their mildly 
or moderately demented patients (Raivio et al. 2001). However, this is the group which benefits most from 
rehabilitation (Huusko et al. 2000). Since dementia caries a strong risk factor for hip fractures, the 
number of these patients is evidently growing (Huusko et al. 2000; Buckner and Larson 1987). Therefore, 
in order to select the most suitable surgical method and to minimize the risk for poor rehabilitation 
outcome and prolonged institutional care, cognitive status should be evaluated preoperatively.
Dementia is the obvious reason for difficulties in understanding and learning about weight-bearing 
restrictions. What happens to those who cannot learn to walk in six weeks? According to our study, 
weight-bearing restrictions often mean confining such patients to a chair for six weeks or longer. This 
practice undermines the objectives of rehabilitation. Our study shows that after six weeks many patients 
with dementia never walk again and most of them require permanent institutional care. 
Perhaps the stability of the fracture is more important than previously appreciated because weight- 
bearing restrictions seldom succeed in enabling patients to walk independently. Endoprothetic devices 
fixed with acrylic cement may be a surgical method for elderly people if stable osteosynthesis is 
impossible. Although the subgroups of weight-bearing without restrictions and with restrictions also 
reflect subgroups of fractures (i.e., stable osteosynthesis or endoprothesis versus unstable fracture 
fixation), the difference in outcome is clear. Regardless of possible dementia, most elderly patients would 
benefit from surgical management of hip fractures requiring no weight-bearing restrictions.
7.2 Use of medication among elderly patients with dementia
7.2.1 Potentially inappropriate medication
In Finland, over a third of elderly patients in nursing homes and acute hospitals use potentially 
inappropriate medications. High-dose temazepam explains the majority of this problem. No differences 
were found in the proportions or use of various classes of PIDs among patients with and without dementia. 
The use of PIDs had no impact on mortality or on days spent in acute hospitals.
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The proportion of nursing home and hospital patients using PIDs is much higher (36.2%) than that of 
community-dwelling elderly Finnish people (12.5%) (Pitkälä et al. 2001). The same trend appears in 
other studies: The more frail and dependent the population, the larger the proportion on PIDs. PID use 
among nursing home patients according to the Beers criteria has been studied only in the USA and 
Canada (Beers et al. 1992; Williams et al. 1995; Spore et al. 1997; Dhalla et al. 2002; Lau et al. 2004; 
Perri et al. 2005) and most other studies have used less inclusive criteria, making prevalence figures 
across studies incomparable (Table 16).Only two studies have fully applied the Beers 1997 list of 
inappropriate medications, and they showed even higher use of PIDs among USA nursing home residents: 
50.3% (Lau et al. 2004) and 46.5% (Perri et al. 2005). Dhalla et al. (2002) omitted all dose-dependent 
PIDs from their list, including short-acting benzodiazepines at high doses, which contributed most to the 
usage of our patients.
Table 16. Potentially inappropriate medications among permanently institutionalized patients
Study Country Use on PIDs ,% Criteria used
Beers et al. 1992 USA 40.3 Beers 1991
Williams et al. 1995 USA 12 10 drugs were based on Beers 1991 (20 
drugs were excluded)
Spore et al. 1997 USA 18 on Stuck criteria
25 on Beers Criteria
Stuck 1994 and Beers 1991 criteria
Dhalla et al. 2002 Canada 20.8 Beers 1997, not drug-disease conditions, 
clonazepam added
Gray et al. 2003 USA 22 Beers 1997, clonazepam added
Lau et al. 2004 USA 50.3 Beers 1997
Perri III et al. 2005 USA 46.5 Beers 1997
Raivio et al. 2005 Finland 36.2 Beers 1997, not drug-disease conditions
Notes:
Beers 1991: - 19 medications and 11 doses, frequencies or durations
 - including dose-dependent antipsychotic medications
 - temazepam excluded
The Stuck 1994 criteria are less inclusive than those of Beers 1991
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Hydroxyzine, amitriptyline, and expecially oxybutynin, with their anticholinergic side-effects, may be 
potentially harmful for patients with dementia. Amitriptylin was rarely used among those with dementia 
in Finland. From 1999 to 2000, the only available medication for incontinence in Finland was oxybutynin, 
which may explain its high usage. Nowadays, alternatives also exist. Other PIDs (according to the Beers 
criteria) were fairly rare in the Finnish population. In the USA, the most common PIDs for nursing home 
and hospital patients have been propoxyphene, promethazine, diphenhydramine, hydroxyzine, oxybutynin, 
amitriptyline, cyproheptadine, high-dose iron supplements, digoxin in high doses, and ranitidine (Perri et 
al. 2005; Lau et al. 2005).
The high use of temazepam, which in Finland is used almost solely for insomnia, may be explained by the 
low hospital-staffing rate in Finland both in hospitals and in nursing homes, especially in dementia care 
(Noro et al. 2005). If only one nurse is working during the night and is responsibe for 20 to 40 mostly 
demented patients, the most convenient way to manage is to administer enough hypnotic medication to 
patients who are “too lively” for such circumstances. The association of hypnotic use with falls remains 
uncertain, however, although one study from Michigan (Avidan et al. 2005) suggests that insomnia itself, 
rather than hypnotic use, is associated with risk for falls.
The use of PIDs among elderly persons in geriatric and internal medicine wards have been studied in Italy 
(Onder et al. 2003) and in emergency department wards in the USA (Chin et al. 1999, Caterino et al. 2004) 
with less inclusive criteria than those based on Beers 1997. In a recent Italian study, PID use among in-
hospital geriatric patients had no effect on in-hospital mortality or length of hospital stay (Onder et al. 
2005). This study used the Beers criteria 2003 (not fully applied).
Only a few studies have examined the impact of PID use on mortality or on the use of health services 
(Hanlon et al. 2002; Fillenbaum et al. 2004; Perri et al. 2005; Klarin et al. 2005; Lau et al. 2005). Our 
study showed no effect on two-year risk of death or on the use of health services, although our population 
showed exceptionally high use of PIDs. Many competing causes of death in this vulnerable population 
may explain the high total mortality (46.6%) in the two-year follow-up period. Our results are well in line 
with the findings of previous studies investigating the impact of PIDs on mortality among elderly people 
with shorter follow-up periods (Onder et al. 2005; Hanlon et al. 2002; Klarin et al. 2005; Lau et al. 2005). 
Few studies show that the increased risk for hospital admission (Perri et al. 2005; Klarin et al. 2005; Lau 
et al. 2005) and for use of outpatient services (Fillenbaum et al. 2004) is associated with PID use, but 
none to date has reported the actual total use of hospital days.
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The accuracy and significance of the Beers list of PIDs may be questioned if PID use cannot be verified 
to affect hard outcomes. However, mortality or hospital days may not be the only relevant end-points in 
situations where the remaining lifespan is so short. Acute side-effects and the quality of life, instead of 
mortality, may be more important end-points in frail elderly samples. 
The Beers list could benefit from being updated based on recent findings from prognostic studies. Some 
drugs may be less harmful than previously thought, although frail elderly patients evidently use a lot of 
potentially inappropriate medications and are exposed to different side-effects, which could impair the 
quality of their life.
7.2.2 Use of antipsychotic medication
In our sample of patients with dementia, nearly half received antipsychotics. Neither the use of 
conventional or atypical antipsychotics nor non-use showed any effect on mortality or on hospital 
admissions. On the contrary, the number of hospital admissions was lower among users of conventional 
or atypical antipsychotics than among non-users. In the Cox proportional hazard model, taking into 
account the old age, delirium and frailty of the sample, the effect of atypical antipsychotic use (risperidone, 
olanzapine) in two-year mortality showed lower risk than did non-use. The use of restraints in nursing 
homes and geriatric wards was still in practise in Finland at the time of this study: about 12% of these 
frail, mostly female, patients with dementia had experienced physical confinement to a bed or wheelchair, 
the practice of which almost doubled the mortality risk in our sample. Most (45.2%) of them received no 
antipsychotic medication, 38.7% received conventional, and 16.1% atypical antipsychotics (p = 0.57, Chi 
Square, df 2). However, the statistical power limits the conclusions that can be drawn.
Only one previous study has compared the mortality risk of patients with dementia using any antipsychotic 
medication to that of non-users (Suh and Shah 2005). The results of our two-year follow-up period are in 
line with this previous study with a one-year follow-up period, thus showing lower mortality among 
patients using any antipsychotic medication than among non-users. Another study, with no control group 
of non-users, showed that users of atypical antipsychotics experienced lower mortality than did users of 
conventional antipsychotics (Wang et al. 2005). Our study, with the longest follow-up period to date, 
showed decreasing trends in both the mean number of admissions to hospitals and in the mortality rate. 
Thus, the use of antipsychotics in this particular patient sample may, if at all, be somewhat protective. 
However, since only multivariate analyses showed these results, this should be interpreted cautiously.
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A recent meta-analysis of Schneider et al. (2005) concluded that the use of atypical antipsychotics may 
slightly increase the risk of death, although no such studies of conventional antipsychotics were available 
at that time. Later, a Canadian study suggested that conventional antipsychotics are at least as likely as 
atypical drugs to increase mortality (Wang et al. 2005). Our study enables the comparison of mortality 
risk between these two antipsychotic medication groups and non-users. 
Why do the results of randomized controlled trials differ from those of long-term follow-up studies? 
Firstly, previous randomized studies have typically spanned only a few months. With a longer follow-up 
period of up to two years, the benefits of the antipsychotics may compensate for the risks of their side-
effects. Secondly, many of the randomized controlled trials under strict investigation criteria may have to 
exclude high-risk patients, thus leading to weaker representativeness of the sample. Our patients represent 
the frailest and oldest of dementia patients at high risk for neuropsychiatric symptoms and their 
complications. The antipsychotics may provide even more benefit than harm in this more “real-life” 
sample.
What could be the explanation of a trend that mortality was even higher among patients not receiving 
antipsychotics? In Finland, the vast majority (90%) of nursing home and long-term hospital patients 
suffer from cognitive deficits (Noro et al. 2005). Behavioral disorders are the leading cause of admission 
to nursing homes (Phillips et al. 2003; Laurila et al. 2004a; DeVugt et al. 2005). In addition, over one third 
of these patients in acute geriatric wards suffered from delirium (Laurila et al. 2004b). The behavioral 
symptoms of dementia (Schneiderman 2005) and delirious episodes (Pitkälä et al. 2004) comprise a 
complication hazard that could potentially lead to falls and fractures, to cardiovascular complications, 
and possibly to the use of restraints as well. Thus, such patients with dementia are particularly vulnerable 
to complications. Our previous study found that the vast majority (87.5%) of these dementia patients 
suffered from behavioral symptoms (Pitkälä et al. 2004). Of these patients, 47.8% exhibited psychotic 
symptoms, 20.8%, aggression, and 25.5%, agitation. These symptoms may be considered target symptoms 
for antipsychotic use and may themselves comprise such a hazard for death (Craig et al. 2005; Wilson et 
al. 2005) as well as explain the benefit of the long-term use of antipsychotic medications, which may 
compensate for any harm. 
Several studies have shown that antipsychotic use was much higher in Finland than in other countries 
(Avorn et al. 1995; Gurwitz et al. 2000; Llorente et al. 1998; Lasser et al. 1998; Liperoti et al. 2003; 
McGrath et al. 1996; Oborne et al. 2002; Ford et al. 2002; van Dijk et al. 2000; Ruths et al. 2001; Sorensen 
et al. 2001; Holmquist et al. 2003; Hosia-Randell et al. 2005; Snowdon 1999; Draper et al. 2001). The 
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high prevalence of delirium in hospital settings as well as dementia with frequent behavioural symptoms 
could partly explain this high use (Pitkälä et al. 2004; De Vugt et al. 2005). In 1999 and 2000, when the 
data were collected, atypical antipsychotics were quite new (only risperidine and olanzapine were 
available at that time) and the use of them was rare. Handling very common behavioral disorders in 
dementia care with non-medical means was very limited, especially given the limited availability of 
nursing staff for dementia care in Finland (Noro et al. 2005). Acetylcholinesterase inhibitors (AChEI) are 
recommended nowadays as a first medical choice to handle behavioral disorders in patients with dementia 
(Sink et al. 2005). Use of this medical treatment for dementia in our population was quite rare in 1999 and 
2000; only 3.1% received it. However, this information related to the benefits of AChEIs was unavailable 
in 1999. In conclusion, antipsychotic medication was the primary treatment for such behavioral symptoms 
in patients with dementia in wards lacking sufficient nursing staff. However, even when a specific 
treatment for dementia is ongoing, we sometimes need additional alternatives to treat serious psychotic 
disorders in such patients. The use of antipsychotic medication may be justifiable in some situations, and 
may be a more effective/safer treatment strategy than the use of physical restraints.
The extensive and careful assessment of all patients at baseline is one of the strengths of our sample in 
these two medication-related studies, which benefited from a long and thorough follow-up period of two 
years. Both dementia and delirium were defined critically. Our relatively small number of patients, raising 
the question of the representativeness of our sample, can be considered a limitation of the studies. 
However, our results are in line with the very large, recently published RAI database (n = 7032) of the 
characteristics of nursing home and hospital populations in Finland (Noro et al. 2005). Another limitation 
of our sample, which was not randomized, is that we had examined the medications only at baseline. 
Nevertheless, when antipsychotics are introduced, they are usually continued for long periods of time. 
With regard to the randomization issue, our study can support and complement the results of pure 
randomized studies on selected populations by offering results from a “real-life” situation. 
7.3 Pitfalls in the services received and the unmet needs  
of caregivers of persons with AD 
7.3.1 Use and unmet needs for official services
Our large-scale sample of the spousal caregivers of persons with AD pointed out that the caregivers were 
themselves very old (mean age 78 years), and many of them were in poor health. Marriages among these 
couples frequently exceeded 50 years, and almost half of those with AD were war veterans. The various 
common behavioral symptoms of the spouses with AD demanded the continuous care and support of the 
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caregivers. In addition, physical impairments and incontinence among these home-dwellers with AD 
were surprisingly frequent. Support services in Finland tend to meet the needs of such families rather 
poorly; in addition to financial support, services offerer them include more technical aid and short-term 
respite care in institutions, when what these families actually seek is more services in the home, such as 
physiotherapy, home respite, and house cleaning. Only half announced that they had been offered official 
services when they needed them, and only a third was satisfied. In conclusion, the autonomy aspect of 
these families tended to be poorly realized in our official service system, since only two in three of the 
caregivers felt they had any influence on the services they were offered.
Behavioral symptoms in our sample were surprisingly common, even higher than in some previoud 
population-based studies (Lyketsos et al. 2002). The questions concerning these symptoms were based on 
the well-validated Neuropsychiatric Inventory Scale (Cummings et al. 1994), so our results can be 
considered reliable. However, the questions were asked without their usual time frame of four weeks. 
Therefore, the prevalence of symptoms may reflect their existence over a longer period of time. Two 
studies of home-dwelling AD patients support our results on the high prevalence of behavioral symptoms 
(Engelborghs et al. 2005; Fuh et al. 2005), which constitute the main cause for the breaking point of home 
care and increase the risk for permanent institutional care (Gilley et al. 2004; De Vugt et al. 2005).
The elderly care-giving families of AD patients in our study seemed quite inconspicuous to the official 
Finnish service system. Dissatisfaction with services among caregivers has been reported to be common 
in studies in other countries as well. In one Italian study, Dello Buono reported that only 40% of caregivers 
(N = 120) were satisfied with services (Dello Buono et al. 1999). A US study published 15 years ago 
showed that care-giving families (N = 46) seek opportunities to influence the services they receive 
(MaloneBeach et al. 1992). Those families experienced difficulties in finding appropriate and good-
quality services and had no opportunity to actively participate in the planning of those services, while 
official workers regretted the families’ lack of interest in using the services offered (DelloBuono 1999; 
Zarit and Leitsch 2001). An Australian study (N = 134) showed that unmet needs among care-giving 
families were quite common: 20% had unmet needs for skilled nursing, 33% for domestic help, 24% for 
home respite, 25% for meals-on–wheels, and 28% for respite care in a rest home (Philp et al. 1995). Our 
results are in line with those of this smaller study. The difference in the unmet needs of female and male 
caregivers may/likely reflects traditional gender roles.
The service most often desired by these families was physiotherapy for the spouse with dementia, which 
is seldom offered by the communal service system. As half of the persons with AD in our sample were 
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war veterans, the physiotherapy offered to them was mainly (90%) the annual war veteran rehabilitation 
set by Finnish law. The inequality that currently exists between the war veterans and the females or 
younger males with AD in opportunities to receive community-offered physiotherapy is obvious. If this 
situation in Finnish society continues, almost all the physiotherapy offered to persons with AD will vanish 
when Finland’s war veterans pass away.
Well-organized, tailored services may postpone institutionalization among those at greates risk for it: 
persons with dementia (Mittelman et al. 1996; Eloniemi-Sulkava et al. 2001). The greater the caregiver 
distress, the greater the families’ need for social services or nursing home placement of the person with 
dementia (Ganzer et al. 1994). The stage of dementia as well as physical impairments and behavioral 
symptoms related to dementia affect the needs of the care-giving family (Gordon et al. 1997; Prescop et 
al. 1999), while the physical and mental strain on the caregiver (Hope et al. 1998; Eloniemi-Sulkava et al. 
2001; Pot et al. 2001; Toseland et al. 2002; Thomas et al. 2006) significantly affects his/her need for, use 
of, and satisfaction with such services (Dello Buono et al. 1999).
The persons with AD in our sample, who have been approved by the Social Insurance Institution of 
Finland for reimbursement of AD medication and who have a spousal caregiver at home, may/likely 
represent the most fortunate of dementia patients. They belong to that minority (25%) of all those with 
dementia in Finland who have thoroughly undergone diagnostic procedures by a neurologist, geriatrician, 
or psychogeriatrician, and who have received medication for AD. We can also assume that they have 
received more information about available services than have other patients with dementia. At the end of 
2005, 25 000 such patients existed in Finland. About 65 000 home-dwellers with dementia remain in a 
worse situation with no specific diagnosis or information about services (Viramo and Sulkava 2006). 
Taking this into consideration, our results provide a rather rosy picture of the services and health situation 
of these families, while “real-life”situations may be even worse.
7.3.2 Use and needs for discussion of medico-legal services
Only 4.3% of Finnish persons with AD in our sample used a court-appointed guardian, possibly because 
they all had a spouse taking care of them. Symptoms of dementia over three years, poor functioning, 
depressive symptoms, cooperation difficulties of the person with AD, and caregivers’ heavy physical 
strain were associated with the use of a guardian. Discussions with the doctor about these medico-legal 
issues were quire rare: only 9.9% of these couples had had the opportunity, although almost half sought 
it. These families obviously have an unmet need for information, support, and counselling in ways to cope 
with the weakening ability of the person with AD to handle financial or other affairs.
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It can be assumed that most of the financial powers of attorney were made in bank offices, since they were 
used in 37.8% of these care-giving families. The severity of dementia, such as symptoms of dementia over 
three years, poor functioning, hallucinations, urinary or bowel incontinence, cooperation difficulties of 
the person with AD, and caregivers’ heavy mental or physical strain were associated with the use of 
financial powers of attorney. Arranging a financial power of attorney requires presentation of the person’s 
own will and signature. The factors associated with both guardianship and financial powers of attorney 
reflect the severity of dementia.
 
Only one Italian study with a smaller sample (N = 100) has examined the prevalence of guardianship 
among home-dwelling dementia patients. Our results are quite well in line with those of this Italian study, 
in which 10.4% to 11.5% of persons with AD in a moderate or severe stage, and 7% of the entire sample, 
used a guardians (Ruggieri et al. 2003). In the UK, the prevalence of guardianship among more severe AD 
patients in nursing homes was 23.6% (Janowsky et al, 1993). We did found no previous studies of the use 
of financial powers of attorney or of families’ needs for discussion of these medico-legal issues with a 
doctor. Studies about the needs of care-giving families as a whole have concluded that such families have 
many unmet needs, including the need for discussions and support (Mittelman et al. 1996; Dello Buono 
et al. 1999; Eloniemi-Sulkava et al. 2001).
The society bears the responsibility to protect an incompetent person with deteriorating cognition from 
acting against his/her own best interest. This most likely occurs in moderate stages of dementia (Mäki-
Petäjä-Leinonen 2003). Appointing a legal guardian is one option for legal protection, but Finnish 
legislation aims to restrict/limit as little as possible one’s legal right to make decisions (English website 
of Finnish Ministry of Justice:
www.om.fi/Etusivu/Julkaisut/Esitteet/Holhoustoimipalvelut/Mitenedunvalvojanvoisaada?lang=en).
Based on the duration of symptoms for more than three years, neuropsychiatric symptoms, poor 
functioning, and the urinary or bowel incontinence of AD patients in our sample, we can assume that most 
of our patients were in a moderate stage of dementia. As they were all living with their spouses, other 
means by the family or society may have been enough to protect them, so guardianship was rarely 
necessary. In conclusion, most cases require no guardian and the most sophisticated way to handle such 
situations is with the trustworthy help of those closest to the patient and/or with financial powers of 
attorney. The most challenging situations occur with AD patients who live alone, a group which will 
likely grow in the future as the population ages and long-term marriages become rarer. In such complicated 
situations, a guardian is often needed despite their more rigid nature. Discussion between the doctors and 
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lawyers could be beneficial in creating a modern service system for such families in Finnish society. We 
agree with previous researchers on the need for regularly renewed national guidelines, which do not yet 
exist in Finland. Care-giving families would benefit from discussions with a doctor and/or with a lawyer 
about these issues as soon as possible after diagnosis. This could help persons with AD in their individual 
planning of the future.
The strength these national data on available services was a cross-sectional large-scale sample of home-
dwellers with properly diagnosed and medically treated AD living with their spousal caregivers. The 
response rate was very high, taking into account the caregivers’ old age. Because our study was a cross-
sectional survey, we are unable to investigate the time span of the needs and symptoms in these families, 
which is a limitation of this study. Nor do we know the exact severity of the care recipients’ AD, but based 
on the duration of the symptoms and the behavioral and physical disorders, we can assume that most of 
them were in a moderate stage of dementia. This home-dwelling sample represents the most fortunate 
group of AD sufferers in Finland; in “real life”, many persons with AD remain undiagnosed or may live 
alone. Consequently, we have no data on those who may face the most challenging problems, which is a 
limitation of our study. However, our results suggest that our official service system should also respond 
to the medico-legal information needs of these patients and their families.
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8 CONCLUSIONS
I. A hip fracture is one of the most dangerous fractures for the elderly, with high mortality and function 
decline. All patients, especially those with dementia, stand to benefit from the possibility to walk normally 
with no weight-bearing restrictions after surgery, fracture type and chosen surgical method permitting, of 
course. The dementia status of the patient should be evaluated preoperatively, which remains a challenge 
for surgeons. The group that stands to benefit most from rehabilitation is that with mild or moderate 
dementia. Elderly hip fracture patients with dementia may benefit from surgery with endoprothetic 
devices fixed with acrylic cement, if stable osteosynthesis is impossible.
II. Over one third of Finnish nursing home and geriatric hospital patients use medications identified as 
PIDs according to the Beers list 1997 and 2003. The most commonly used PID was temazepam, in doses 
exceeding 15 mg, to treat insomnia. However, PIDs showed no impact on two-year mortality or hospital 
admissions. Some medications on the Beers list may be less harmful than previously thought. We 
recommend updating the Beers list based on the findings of prognostic studies.
III. Nearly half of the patients with dementia in Finnish nursing homes and geriatric hospitals received 
antipsychotics. We primarily used conventional antipsychotics, which are cheaper than atypical ones. The 
high drug use had no impact on two-year mortality or hospital admissions in the frail and elderly 
population studied. Whenever a drug treatment for psychotic disorders is needed, atypical antipsychotics, 
with fewer side effects, proved as safe as conventional ones and a better alternative than the use of 
restraints.
IV. Home-dwellers with AD in Finland are surprisingly disabled yet they are still cared for by those 
closest to them. Caregivers do amazingly heavy work, although they themselves are old and sick. 
Finland’s official service system meets the needs of these care-giving families rather poorly. Most of the 
services caregivers seek, such as home respite, home cleaning, or physiotherapy for the person with AD, 
are either insufficient or do not exist. In addition, our service system is fragmented and complex, making 
it difficult for the families to understand. More services tailored to these families are needed.
V. One unmet need of these families was counselling in medico-legal affairs, such as guardianship. 
Receiving adequate information about options for handling such issues as soon as possible after the 
diagnosis of dementia would be in the best interest of the family. We recommend more cooperation with 
the lawyers and doctors who handle such affairs as well as creating national guidelines.
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9 FUTURE DIRECTIONS AND CLINICAL ImPLICATIONS
Persons with dementia are the most challenging group to care for and to live with. Unless caregivers take 
total, 24/7 responsibility of them, the aid provided by our social and health care system is sorely needed. 
Financial community support and organized information should be available to all caregivers regardless 
of age, activity, education level or living conditions.
Our study showed that one of the most desired/sought-after services was physiotherapy for the AD 
sufferer. At present, insufficient data are available on the impact of physiotherapy in such situations, but 
some recent studies have shown promising results (Teri et al. 2004, Rolland et al. 2007). More studies are 
needed to investigate the long-term effect of physiotherapy on AD sufferers. Finland has been active in 
creating special fitness centers for the elderly, which now exist in most cities. Nevertheless, we have a 
solid basis to begin wide-scale organized physical rehabilitation of such elderly patients, particularly if 
future studies reveal positive results among persons with AD.
A rehabilitative attitude is not limited to physical aspects, but includes social, medical and emotional 
care. In Finland, persons with dementia may suffer from underdiagnosis and inappropriate medication, 
especially the high and long-term use of antipsychotics (Löppönen 2006). Education is available to 
doctors, and the use of antipsychotics seems to be connected to the low staffing rate in Finnish nursing 
homes, which is currently only half of recommended rates (Noro et al. 2005). We also suffer from a lack 
of sufficiently trained staff. This is an ethical and political problem that cannot be remedied by health care 
workers alone. More discussions and cooperation is needed between the Ministry of Social and Health 
Care, ethics committees, and social and health care workers.
One recent Finnish study revealed very positive results citing cost savings of up to EUR 8 000 annually 
per family by offering multidimensional services organized by a coordinator to care-giving families of 
dementia patients. This intervention consisted also emotional support for caregivers. In this study, most 
savings came from a decrease in the use of institutional care (Eloniemi-Sulkava et al. 2006). In Finland, 
where 50% to 60% of 85 000 patients with moderate or severe dementia dwell in communities, 15 000 of 
whom are cared for by their spouses, this model promises savings of EUR 75 million annually.
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Elderly people, especially those with dementia, benefit from appropriate medical and surgical care, which 
allows them to remain mobile as long as possible. Caregivers themselves regarded their work most as 
emotionally stressful, while our society tends to offer them mostly physical devices or solutions. 
Emotional support and information about available services need new strategies. Such families require 
more cooperation and education with the lawyers and doctors who handle medico-legal issues. Preparing 
national guidelines for assessing cognitive and mental capacity could be valuable. In addition, creating 
new vacancies for dementia coordinators in the Finnish health and social care system could provide more 
tailored services for such care-giving families and thus postpone permanent institutional care.
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Teemme tutkimusta omaishoitajien saamista palveluista ja tuesta sekä niiden tarpeesta. Kelan 
rekisteritiedon mukaan puolisonne sairastaa dementoivaa sairautta ja sen vuoksi olette mahdollisesti 
saanut tai ollut tekemisissä joidenkin tukipalveluiden kanssa. Toivoisimme Teidän vastaavan oheiseen 
kyselyyn joka tapauksessa, vaikka ette mitään palvelua olisi saanutkaan. Tarkoituksenamme on kartoittaa 
palveluiden alueellista jakaantumista Suomessa. Haluamme selvittää omaisten kokemuksia dementiaa 
sairastavan hoidosta sekä tutkia, miten erilaiset dementiaan liitetyt oireet ja omaishoitajan terveys ovat 
yhteydessä palveluiden ja tuen saatiin. 
Tutkimuksen perusteella voidaan palveluita kehittää paremmin vastaamaan omaishoitoperheiden 
tarpeita.
Tutkimukseen osallistuminen on vapaaehtoista. Kerättävät tiedot ovat luottamuksellisia, ja ne julkaistaan 
niin, että yksittäistä vastaajaa ei pystytä niistä tunnistamaan. Tutkimuksen kaikissa vaiheissa tullaan 
noudattamaan henkilötietolain ja potilastietosuojalain säännöksiä. Tutkimukseen osallistuminen ei 
vaikuta muuhun mahdolliseen hoitoonne ja saamiinne palveluihin.
Vastatkaa kysymyksiin ja palauttakaa lomake 21.11.2005 mennessä oheisessa palautuskuoressa.
Tarvittaessa lisätietoja tutkimuksesta antaa geriatrian erikoislääkäri 
Minna Raivio p. 040- 415 3122.
Ystävällisin terveisin
Reijo Tilvis Kaisu Pitkälä






Tämä on kysely dementiaa sairastavan puolisolle. Pyydämme Teitä lukemaan koko kysymyksen 
ennen vastaamista. Rengastakaa mielestänne lähinnä oikea vaihtoehto ja vain yksi vaihtoehto, jos 




 1. naimisissa tai avoliitossa, _____________ vuotta
  2. naimaton
  3. asumuserossa tai eronnut
 4. leski (olen ollut leskenä ____vuotta)
Jos olette naimisissa puolisonne kanssa, rengastakaa kohta 1 ja kirjoittakaa tyhjään tilaan 
avioliittovuosien määrä.
Yrittäkää vastata kaikkiin kysymyksiin.
Pyytäkää tarvittaessa apua lähiomaiseltanne tai läheiseltänne.
Vastauksenne ovat ehdottoman luottamuksellisia.
Täytetyn lomakkeen voitte laittaa oheisessa jo valmiiksi maksetussa palautuskirjekuoressa 
postilaatikkoon.
Osoitelähde: Kansaneläkelaitos Alzheimer lääkettä saavien rekisteri
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ALUKSI KYSYMME TAUSTATIETOJANNE
1. Mikä on Teidän siviilisäätynne? 2. Mikä on sukupuolenne?
 1. naimisissa tai avoliitto _____ vuotta  1. nainen
 2. naimaton  2. mies
 3. asumuserossa tai eronnut
 4. leski (olen ollut leskenä _____ vuotta)
3.a. Ikänne ________ 3.b. Puolisonne ikä ________
4.a. Koulutuksenne? 4.b. Puolisonne koulutus
 1. kansakoulu tai vähemmän  1. kansakoulu tai vähemmän
 2. ammattikoulu  2. ammattikoulu
 3. keskikoulu  3. keskikoulu
 4. lukio  4. lukio
 5. opistoasteen ammattikoulutus  5. opistoasteen ammattikoulutus
 6. korkeakoulu  6. korkeakoulu
5. Asutteko puolisonne kanssa 
 1 Kyllä    2 Ei 
6. Missä asutte? 1. kotona
 2. palvelutalossa
 3. pysyvästi vanhainkodissa tai hoivakodissa
 4. pysyvästi sairaalassa
 5. muualla, missä _________________________________________
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7. Hoidatteko kotona dementiaa sairastavaa puolisoanne?
 1 Kyllä   2 Ei 
8. Jos puolisonne ei asu kanssanne, missä hän asuu
 1. Palvelutalossa
 2. Pysyvästi vanhainkodissa tai hoivakodissa
 3. Pysyvästi sairaalassa
 4. Muualla, missä? ___________________________________________




SEURAAVAKSI KYSYMME TEIDÄN JA PUOLISONNE NYKYISESTÄ 
TERVEYDENTILASTA JA TOIMINTAKYVYSTÄ
10. Millaisena pidätte omaa terveydentilaanne tällä hetkellä?
 1. Pidän itseäni terveenä
 2. Pidän itseäni melko terveenä
 3. Pidän itseäni sairaana
 4. Pidän itseäni hyvin sairaana
11.a. Onko oma toimintakykynne tai kuntonne yleisesti ottaen tällä hetkellä mielestänne




 5. erittäin huono
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11.b. Onko puolisonne toimintakyky tai kunto yleisesti ottaen tällä hetkellä mielestänne




 5. erittäin huono
12 a. Onko oma yleiskuntonne sellainen että pystytte vaivatta liikkumaan sisällä?
 1. Kyllä 
 2. ei, tarvitsen kepin tai rollaattorin
 3. ei, tarvitsen toisen henkilön tukea
 4. ei, en pysty kävelemään
12. b. Onko puolisonne yleiskunto sellainen että hän pystyy vaivatta liikkumaan sisällä?
 1. Kyllä 
 2. ei, hän tarvitsee kepin tai rollaattorin
 3. ei, hän tarvitsee toisen henkilön tukea
 3. ei, hän ei pysty kävelemään
12. c. Onko puolisollanne seuraavia liikkumista haittaavia oireita? 
 1. Jäykkyyttä a. kyllä b. ei
 2. Huimausta a. kyllä b. ei
 3. Lihasheikkoutta a. kyllä b. ei
 4. Kipuja a. kyllä b. ei
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SEURAAVAKSI MUUTAMA KYSYMYS ELÄMÄNASENTEISTANNE 
13. Oletteko tyytyväinen elämäänne?  1 kyllä 2 en 
14. Tunnetteko itsenne tarpeelliseksi?  1 kyllä 2 en
 
15. Onko Teillä tulevaisuudensuunnitelmia?  1 kyllä 2 ei
 
16. Onko Teillä elämänhalua?  1 kyllä 2 ei 
 
17. Oletteko masentunut?  1. harvoin tai ei koskaan
  2. toisinaan
  3. usein tai aina
18. Kärsittekö yksinäisyydestä?  1. harvoin tai ei koskaan 
 2. toisinaan
 3. usein tai aina 
SEURAAVAKSI KYSYMME TEILLE TÄRKEISTÄ IHMISISTÄ JA SEURAELÄMÄSTÄNNE
19. Millaisena koette nykyisen suhteen puolisoonne? 




 5. Erittäin epätyydyttävänä
20. Onko Teillä lapsia (elossa olevia)?  1 Kyllä  2 Ei 
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21. Tapaatteko lapsianne niin usein kuin haluaisitte?  1 Kyllä  2 En 
22. Onko Teillä ystäviä, joihin pidätte säännöllisesti yhteyttä? 
 1 Kyllä  2 Ei
23. Tapaatteko ystäviänne niin usein kuin haluaisitte?  1 Kyllä  2 En 
24. Tuntuuko Teistä että läheisenne ymmärtävät elämäntilannettanne?
 1. läheiseni ymmärtävät hyvin 
 2. läheiseni ymmärtävät kohtalaisesti 
 3. läheiseni eivät ymmärrä
SEURAAVAKSI KYSYMME PUOLISONNE DEMENTIAAN MAHDOLLISESTI  
LIITTYVISTÄ OIREISTA
25. Edellyttääkö puolisonne hoito jatkuvaa läsnäoloanne?
 1 Kyllä 2 Ei, voin jättää häntä yksin vuorokauden aikana keskimäärin ______ tunniksi
26. Vaikuttaako puolisonne surulliselta tai masentuneelta?
 1 Kyllä  2 Ei 
27. Onko puolisonne ajoittain levoton, ahdistunut tai ärtyisä?
 1 Kyllä  2 Ei 
28. Onko tilanteita, jolloin puolisonne kieltäytyy yhteistyöstä tai ei ota vastaan apua?
 1 Kyllä  2 Ei 
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29. Onko puolisollanne aistiharhoja, esimerkiksi näkö- tai kuuloharhoja? Vaikuttaako siltä, että 
hän näkee, kuulee tai kokee olemattomia asioita?
 1 Kyllä  2 Ei 
30. Onko puolisollanne virtsan tai ulosteen pidätysvaikeuksia?
 1. Kyllä   2. Ei
SEURAAVAKSI KYSYMME NYKYISESTÄ ARKIELÄMÄSTÄNNE JA JAKSAMISESTANNE 




32. Koetteko puolisonne hoitamisen henkisesti rasittavana?
 1 Kyllä 2 Ei
33. Estääkö puolisonne hoitaminen Teitä ottamasta osaa normaaliin kanssakäymiseen muiden 
ihmisten kanssa? (kuten vierailut ystävien luo, vapaa-ajan harrastukset)?
 1. Kyllä  2. Ei
34. Onko puolisonne hoitaminen ruumiillisesti raskasta?
 1. Kyllä  2. Ei
35. Häiritseekö puolisonne sairaus yöuntanne?
 1. Kyllä 2. Ei
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36. Oletteko joutunut muuttamaan uuteen asuntoon puolisonne sairauden aikana tai sen vuoksi?
 1. Kyllä 2. Ei
SEURAAVAKSI KYSYMME PUOLISONNE DEMENTIAAN LIITTYVÄSTÄ 
TIEDONSAANNISTA
37. Milloin Teidän mielestänne puolisollanne alkoi esiintyä muistivaikeuksia tai muita 
dementiaoireita?
 1. Alle vuosi sitten
 2. 1-2 vuotta sitten
 3. 3-4 vuotta sitten
 4. 5 vuotta tai yli 5 vuotta sitten
38. Missä puolisonne dementiaa selvittävät tutkimukset tehtiin? (rengastakaa yksi tai useampia 
seuraavista) 
 1. terveysasemalla
 2. sairaalan poliklinikalla
 3. yksityislääkärin vastaanotolla
 4. muualla, missä__________________________________________
39. Kun puolisonne muistin heikentymisen vuoksi tehtyjen tutkimusten tulokset valmistuivat, 
olitteko vastaanotolla mukana kuulemassa tutkimustuloksia?
 1. Kyllä  2. Ei 
 
40. Kerrottiinko puolisollenne tai Teille suoraan, että kyse voi olla dementiasta? 
 1. Kyllä  2. Ei 
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41. Jos puolisollenne tai Teille kerrottiin dementiasta, puhuttiinko siinä yhteydessä dementian 
oireista ja kestosta? 
 1. Kyllä 
 2. Kyllä, muttei riittävästi 
 3. Ei lainkaan 
42. Oletteko mielestänne saanut riittävästi tietoa puolisonne dementiasairaudesta ja sen oireista?
 1. Kyllä 2. Ei 
 
43. Mistä olette saanut tietoa? (rengastakaa yksi tai useampia seuraavista)
 1. Lääkäriltä
 2. Muilta terveydenhuollon tai sosiaalihuollon työntekijöiltä
 3. Vapaaehtoisjärjestöiltä (esimerkiksi Alzheimer- tai dementiayhdistyksiltä)
 4. Tiedotusvälineistä, kirjoista
 5. Omaisilta, ystäviltä
 6. Muualta, mistä? _______________________________________________________
44. Missä dementiasairauden jatkohoito tapahtui (rengastakaa yksi tai useampia seuraavista)
 1. terveysasemalla
 2. sairaalan poliklinikalla
 3. yksityislääkärin vastaanotolla
 4. muualla, missä _______________________________________________________
 5. ei missään 
45. Onko dementiasairauden jatkohoito järjestetty mielestänne hyvin?
 1 Kyllä  2 Ei 
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46. Onko puolisonne tai oletteko Te itse kertonut puolison dementiasairaudesta läheisillenne, esim. 
lapsillenne?
 1 Kyllä  2 Ei
47. Onko puolisonne tai oletteko Te itse kertonut puolison dementiasairaudesta ystävillenne? 
 1 Kyllä  2 Ei
48. Aiheuttiko tietoisuus sairaudesta ja sen kulusta masennusta puolisollenne?
 1 Kyllä  2 Ei
49. Aiheuttiko tietoisuus sairaudesta ja sen kulusta masennusta Teille?
 1 Kyllä 2 Ei 
50. Onko mielestänne hyvä asia, että lääkäri kertoo potilaalle
a) suoraan dementiasairauden diagnoosin?  1 Kyllä 2 Ei 
b) dementiaan liittyvistä oireista ja ongelmista  1 Kyllä 2 Ei 
51. Onko mielestänne hyvä asia, että lääkäri kertoo omaiselle
a) suoraan dementiasairauden diagnoosin?  1 Kyllä  2 Ei
 
b) dementiaan liittyvistä oireista ja ongelmista ?  1 Kyllä  2 Ei 
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SEURAAVAKSI KYSYMME TEILTÄ, MITEN OLETTE VARAUTUNEET MAHDOLLISEEN 
TERVEYDENTILAN MUUTOKSEEN
52. Oletteko tehneet valtakirjan pankissa tai jonkin laajemman valtuutuksen puolisonne 
taloudellisten asioiden hoidon helpottamiseksi?
 1 Kyllä  2 Ei
 
53. Oletteko hakeneet virallista edunvalvojaa puolisollenne taloudellisten tai muiden asioiden 
hoidon helpottamiseksi?
 1 Kyllä 2 Ei
 
a) Oletteko keskustellut näistä asioista puolisoanne hoitavan lääkärin kanssa?
 1 Kyllä 2 Ei
b) Haluaisitteko keskustella näistä asioista puolisoanne hoitavan lääkärin kanssa?
 1 Kyllä  2 Ei
54. Oletteko keskustelleet puolisonne kanssa hänen hoitotoiveistaan mahdollisen  
vakavan sairauden varalle?
 1 Kyllä 2 Ei
 
a) Onko puolisonne kirjannut paperille henkilökohtaisia hoitotoiveitaan 
(nk. hoitotestamentti) vakavan sairauden varalle? 1 Kyllä 2 Ei
b) Oletteko keskustellut näistä asioista puolisonne lääkärin kanssa?
 1 Kyllä 2 Ei
c) Haluaisitteko keskustella näistä asioista puolisoanne hoitavan lääkärin kanssa?
 1 Kyllä  2 Ei
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ALLA ON LUETELTU JULKISIA PALVELUJA. RENGASTAKAA JOKAISEEN KOHTAAN, 
ONKO PERHEENNE SAANUT KYSEISTÄ PALVELUA JA OLISIKO PERHEELLÄNNE 
OLLUT TARVE SAADA TÄTÄ PALVELUA.
55. Kotiin tuodut sairaanhoidolliset palvelut puolisollenne 
(esim. lääkkeiden jako, haavanhoito)
a Onko puolisonne saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos puolisonne ei ole saanut, olisiko hänellä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
56. Kotiin tuotu apu puolisonne henkilökohtaisissa toimissa (esim. peseytyminen tai 
muu päivittäisissä tarpeissa avustaminen)
a Onko puolisonne saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos puolisonne ei ole saanut, olisiko hänellä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
57. Siivouspalvelu
a Oletteko saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos ette ole saanut, olisiko Teillä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
58. Ateriapalvelu
a Oletteko saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos ette ole saanut, olisiko Teillä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
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59. Fysioterapia (kuntoutus) 
a Onko puolisonne saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos puolisonne ei ole saanut, olisiko hänellä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
60. Kunnan toimesta järjestetty apuväline (esim. WC-istuimen koroke, rollaattori)
a Onko puolisonne saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos puolisonne ei ole saanut, olisiko hänellä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
61. Kuljetustuki (yhteiskunnan kustantama taksikortti tai muu kuljetuspalvelu)
a Onko puolisonne saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos puolisonne ei ole saanut, olisiko hänellä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
62. Kunnan toimesta annetut vaipat
a Onko puolisonne saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos puolisonne ei ole saanut, olisiko hänellä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
63. Päivätoiminta
a Onko puolisonne saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos puolisonne ei ole saanut, olisiko hänellä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
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64. Lyhytaikaishoitojakso (esim. ns. intervallijakso vanhainkodissa tai muussa hoitopaikassa)
a Onko puolisonne saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos puolisonne ei ole saanut, olisiko hänellä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
65. Kotiin tuleva sijaishoitaja joka mahdollistaa Teidän irrottautumisenne puolisonne hoidosta 
a Oletteko saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos ette ole saanut, olisiko Teillä ollut tarvetta tähän palveluun?
 1 Kyllä  2 Ei
66. Kunnan Teille maksama rahallinen korvaus työstänne omaishoitajana 
(omaishoidontuki) 
a Oletteko saanut tätä tukea ? 1 Kyllä  2 Ei
b Jos ette ole saanut, olisiko Teillä ollut tarvetta tähän tukeen? 1 Kyllä  2 Ei
67. Teille kunnan antamat palvelusetelit, joilla olette voinut ostaa puolisonne hoitoon tarvittavia 
yksityisiä palveluja?
a Oletteko saanut tätä palvelua? 1 Kyllä  2 Ei
b Jos ette ole saanut, olisiko Teillä ollut tarvetta tähän palveluun? 1 Kyllä  2 Ei
68. Oletteko ollut tyytyväinen saamiinne tukipalveluihin?
 a. erittäin tyytyväinen
 b. melko tyytyväinen
 c. en tyytyväinen enkä tyytymätön
 d. melko tyytymätön
 e. erittäin tyytymätön
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70. Oletteko Te osallistunut omaishoitajien tukiryhmiin (esimerkiksi vertaistukitoimintaan)?
 1 Kyllä  2 Ei
71. Jos ette ole osallistunut omaishoitajien tukiryhmiin, olisiko Teillä tarvetta tällaiseen 
ryhmätoimintaan?
 1 Kyllä  2 Ei
72. Onko puolisonne sotaveteraani tai sotainvalidi? 
 1 Kyllä 2 Ei
73. Onko puolisonne saanut viimeisen vuoden aikana sotainvalidi- tai veteraanikuntoutusta?
 1 Kyllä 2 Ei
74. Oletteko hankkinut perheellenne yksityisesti seuraavia palveluja (ympyröikää kaikki 
käyttämänne palvelut)
 1 Kotiin tuodut sairaanhoidolliset palvelut puolisollenne
 2 Kotiin tuotu apu puolisonne henkilökohtaisissa toimissa
 3 Ateriapalvelu
 4 Siivouspalvelu
 5 Kotiin tuleva sijaishoitaja, joka mahdollistaa Teidän irrottautumisenne puolisonne hoidosta




 10 Lyhytaikaishoito (esim. ns intervallijakso vanhainkodissa tai muussa hoitopaikassa)
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75. Onko teidän ollut helppo saada tietoa tarjolla olevista tukipalveluista dementiaperheille?
 a. erittäin helppoa
 b. melko helppoa
 c. ei helppoa eikä vaikeaa
 d. melko vaikeaa
 e. erittäin vaikeaa
 
76. Saatteko mielestänne riittävästi käytännöllistä apua puolisonne hoitamiseen?
 1. Lapsiltanne a. Kyllä b. En
 2. Ystäviltänne a. Kyllä b. En
 3. Muilta sukulaisilta tai tuttavilta a. Kyllä b. En
 4. Oman kunnan palveluilta a. Kyllä b. En
 5. Muualta, mistä_____________
77. Saatteko mielestänne riittävästi henkistä tukea puolisonne hoitamiseen?
 1. Lapsiltanne a. Kyllä b. En
 2. Ystäviltänne a. Kyllä b. En
 3. Muilta sukulaisilta tai tuttavilta a. Kyllä b. En
 4. Oman kunnan palveluilta a. Kyllä b. En
 5. Muualta, mistä ______________
78. Onko teillä selkeä käsitys, keneen/ minne otatte yhteyttä, jos puolisonne sairaudessa tulee 
ongelmatilanteita?
 1 Kyllä, keneen/ minne         
 2 Ei
79. Oletteko saanut julkisia palveluja puolisonne hoitoon silloin, kun olette niitä tarvinnut?
 1 Kyllä 2 Ei
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80. Oletteko mielestänne voinut vaikuttaa riittävästi siihen, mitä julkisia palveluita perheenne 
saa?
 1 Kyllä 2 Ei
81. Millaisia ongelmia olette kohdannut palveluita tarvitessanne? 
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
Sydämellinen kiitos vaivannäöstänne!
